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Abstract 
 Hoxa2 null embryos display a high incidence of cleft secondary palate which 
has previously been described as secondary to altered tongue development.  The 
experiments described in this thesis demonstrate that expression of Hoxa2 does 
occur within the developing palate, with the highest levels appearing in the early 
stages of palatogenesis (E12.5 and E13.5).  Increased cell proliferation was 
observed throughout the palate in the absence of Hoxa2, without a detectable 
difference in apoptosis or the ability of the shelves to fuse.  In addition, the palate 
shelves of the null embryos failed to elevate above the tongue, suggesting a 
mechanism by which the increased cell proliferation results in cleft palate.   
 Numerous downstream targets of Hoxa2 were also identified in the palate 
(Msx1, Bmp4, Barx1, Ptx1, Six2, Lef1 and Tbx1).  In all cases, Hoxa2 appears to act 
as a transcriptional repressor.  Increases in palatal Msx1, Bmp4 and Barx1 
expression have all been previously described to lead to increases in cell 
proliferation.  Hoxa2, Ptx1, Lef1 and Tbx1 may be involved in a novel pathway that 
regulates proliferation in the palate.  In addition, three novel gene targets were 
identified in the palate, Six2, Fgf8 and Htra3.   
 Together these data show that there is a direct role for Hoxa2 in regulating 
palate development, apparently through regulating the expression of downstream 
genes involved in maintaining normal cell proliferation rates.   
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1.0 Introduction 
Cleft palate is one of the most common congenital birth defects in the 
human population, occurring with a frequency of 1:400-1000 (Gorlin et al., 
2001).  A complex network of interaction between signalling molecules is 
required for the proper growth and development of the palate shelves.  In the 
embryonic mouse, secondary palate development begins at E11.5 with the 
palate shelves budding out of the maxillary prominences.  From that point until 
E14.0 the palate shelves grow vertically down either side of the tongue.  At 
E14.0, the tongue drops and the palates undergo a rapid elevation to become 
oriented horizontally above the tongue and then grow together and contact at 
E14.5 at which point the palate shelves fuse together to form a complete palate 
(Ferguson, 1988).  Defects at any stage of this tightly regulated developmental 
process can result in a cleft secondary palate.   
Hoxa2 has been shown to be the selector gene for the second branchial 
arch (Grammatopoulos et al., 2000; Hunter and Prince, 2002; Pasqualetti et al., 
2000; Santagati et al., 2005) while being completely absent from the first 
branchial arch from which the secondary palate is derived (Prince and 
Lumsden, 1994).  The absence of Hoxa2 expression in the first branchial arch 
suggested that it could not play a direct role in palatogenesis despite an 81% 
incidence of cleft palate in Hoxa2 null embryos. Therefore, altered tongue 
musculature was suggested as the defect resulting in the observed cleft 
(Barrow and Cappechi, 1999; Gendron-Maguire et al., 1993; Rijli et al., 1993).  
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Recently, Hoxa2 expression was reported in the developing palate suggesting a 
more direct role for the gene in regulating palatogenesis (Nazarali et al., 2000). 
Further analysis of any potential role of Hoxa2 in the development of the palate 
is required. 
The regulation of the growth and development of the secondary palate 
has been shown to be dependent on a complex network of signalling pathways 
that have been intensely investigated (reviewed in Gritli-Linde, 2007).  The 
expression of many of these genes display closely regulated localized 
expression.  In many cases these genes are epithelial or mesenchymal specific.  
In addition, a number of genes display specific localization along the 
anteroposterior axis of the palate.  Distinct pathways have been shown to be 
involved in regulating the growth, elevation and the fusion of the palate shelves.  
There is a possible role for Hoxa2 in the regulation of these complex pathways 
but this has not previously been investigated and has been addressed in this 
thesis. 
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2.0 Hypothesis 
 Hoxa2 has one or more downstream targets within the developing 
murine palate, and through regulating the expression of these genes, Hoxa2 
acts to maintain normal cell proliferation within the palate. 
Objectives 
1. To determine whether Hoxa2 plays an important role in the regulation of any 
or all of the following processes within the developing murine palate: 
– Cell proliferation 
– Cell survival or apoptosis  
– Fusion and degradation of the medial edge epithelium   
2. To determine putative downstream targets of Hoxa2 in the murine palate 
involved in one or more of the processes outlined in objective 1. 
3. To determine if Hoxa2 affects the expression of its putative downstream 
target genes in the developing palate. 
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3. Literature Review 
3.1 Overview of Craniofacial Development  
 Development of the face requires precise coordination of the growth, 
differentiation and convergence of numerous populations of cells called facial 
prominences/processes (Helms et al., 2005).  The patterning of the face begins 
significantly before the overt growth of these facial prominences.  Early in 
vertebrate development the anterior region of the neural tube differentiates into 
the forebrain (prosencephalon), midbrain (mesencephalon) and the hindbrain 
(rhombencephalon) (Gilbert, 2003; Lumsden and Keynes, 1989).  The 
ectodermal neural folds of the neural tube located between the neuroectoderm 
and the epidermis then undergo a transition from ectoderm to mesenchyme.  
These ectomesenchymal cells, called neural crest cells (NCC), are pluripotent 
and as such can give rise to a range of diverse tissue types (reviewed in 
Gammill and Bronner-Fraser, 2003; Le Douarin and Kalcheim, 1999) (Fig. 1).   
As embryonic development proceeds the hindbrain becomes further segmented 
into smaller compartments called rhombomeres.  The rhombomeres represent 
distinct populations of cells that do not mix with cells from other compartments 
(Guthrie and Lumsden, 1991; Guthrie et al., 1993).  These cells also express 
distinct subsets of genes that lead to different developmental fates (Fraser et 
al., 1990).  
3.2 Cranial Neural Crest Cell Migration 
Migration of cranial neural crest cells (CNCC) gives rise to the bulk of the  
 5 
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Figure 1. Schematic Representation of Neural Crest Formation. 
The above is a schematic representation of an amniote embryo. A)  Represents 
the stage following the development of the primitive streak denoted by the 
depression in the center.  The area in between the black represents the 
neuroectoderm.  B) The neuroectoderm then fold at the neural folds (black), 
which contact one another and fuse forming the neural tube.  C) The neural 
crest cells originate from the junction between the epidermal ectoderm and the 
presumptive neural ectoderm, and then migrate away from the neural tube to 
form a variety of structures throughout the developing embryo.  Adapted from 
Gilbert, 2003. 
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cells that compose the face (Gammill and Bronner-Fraser, 2003).  
Establishment of the anteroposterior axis of the embryo as well as directing the 
migration of CNCC is believed to be regulated by the expression of homeobox 
(Hox) genes (reviewed in Noden and Trainor, 2005; Santagati and Rijli, 2003; 
Trainor and Krumlauf, 2001).  Hox genes are differentially expressed between 
rhombomeres and in general migrating CNCC express the same subset of Hox 
genes as the rhombomeres from which they arose (Helms et al., 2005; Le 
Douarin et al., 2004; Noden and Trainor, 2005).  Further description of the 
expression and function of Hox genes will be discussed in section 3.5 (pg. 46).   
 Five facial prominences/processes [the frontonasal process (FNP), a 
pair of maxillary processes (MXP) and a pair of mandibular processes (MDP)] 
act as the building blocks of the vertebrate face (Fig. 2).  Each of these 
processes is composed of migrating CNCC with a core of mesoderm cells and 
is overlaid by surface ectoderm.  CNCC will go on to become the facial skeleton 
while the mesoderm cells will eventually compose the facial musculature 
(Noden, 1983; Noden, 1988; Noden and Trainor, 2005).  The FNP is comprised 
of CNCC from the mesencephalon migrating over the prosencephalon.  
Migrating CNCC from the posterior mesencephalon as well as rhombomeres 
form the six branchial (pharyngeal) arches (Fig. 2).  These arches are 
separated externally by visible ectodermal grooves as well as internally by 
endodermal pharyngeal pouches (Sperber and Sperber, 2009).  CNCC from the 
posterior mesencephalon and rhombomeres 1 and 2 populate the first 
 8 
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Figure 2. Schematic Representation of Facial Development 
Schematic representation of the development of the murine face, from 
the stage of branchial arch (BA) development to the completed face.  The face 
is developed from the growth and convergence of five facial prominences.  The 
frontonasal prominence (yellow) originates from the mesencephalon and forms 
the forehead and portions of the nose.  The maxillary prominence (green) is 
derived from rhombomere 1 & 2 contributes to the formation of the upper lip and 
primary palate. The mandibular prominence (blue) forms the lower lip, mandible 
and the anterior portion of the tongue. The nose is composed primarily of the 
medial nasal prominence (purple) and the lateral nasal prominence (red) which 
are differentiated from the FNP. 
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branchial  arch.    The first branchial arch gives rise to the MXP and MDP.  The 
second branchial arch is populated from CNCC migrating from the fourth 
rhombomere and goes on to form the stapes and styloid process (bones of the 
middle ear) and the hyoid bone to which the tongue muscles attach.  The third 
and fourth branchial arches are composed of CNCC from rhombomeres 6-8 
(Bronner-Fraser, 1993; Lumsden and Krumlauf, 1996; Osumi-Yamashita et al., 
1990; Selleck et al., 1993; Serbedzija et al., 1992). The cells in rhombomeres 3 
and 5 undergo massive apoptosis prior to migration and therefore do not 
significantly contribute to populating any of the branchial arches (Graham et al., 
1993). 
3.3 Facial Development   
The convergence of the facial prominences is responsible for forming the 
embryonic face (reviewed by Jiang et al., 2006; Sperber and Sperber, 2009).  
The center of the developing face is the primitive mouth or stomodeum.  The 
stomodeum is a central depression lined by the oropharyngeal membrane.  This 
membrane marks the boundary between the endoderm of the future throat and 
the ectoderm of the future mouth.  This central feature of the face is surrounded 
by the outgrowths of the facial prominences.  Rostrally the stomodeum is 
bordered by the FNP, laterally it is the MXPs and caudally the MDPs (Ferguson 
et al., 2000; Hinrichsen, 1985)(Fig. 2). 
The FNP contributes to the formation of the embryonic forehead and 
nose.  This process begins with the development of bilateral nasal placodes 
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formed from the inferolateral corners of the FNP.  These nasal placodes then 
appear to sink as the medial nasal prominences (MNP) and lateral nasal 
prominences (LNP) elevate forming a horseshoe shaped structure that 
surrounds the bilateral nasal pits (Hinrichsen, 1985; Sperber, 2002b).  As 
development proceeds the LNPs will continue to elevate to form sides (alae) of 
the nose (Ohbayashi and Eto, 1986).  Growth of the MXPs acts to force 
together the MNPs and LNPs resulting in the nasal pits appearing more like slits 
than the widely spaced nostrils.  Fusion of the MNPs and the LNPs completes 
the formation of the nostrils (Gaare and Langman, 1977; Hinrichsen, 1985; 
O'Rahilly, 1967).  The posterior portion of each of the nasal pits is originally 
separated from the oral cavity by the presence of a transient oronasal 
membrane.  At the end of the fifth week of human embryonic development this 
membrane disappears, allowing the nostrils to be connected to the posterior 
oral cavity (Sperber, 2002b).   
Growth of the MXPs towards the midline results in fusion between the 
MNPs and the MXPs and in the formations of the tip of the nose, the upper lip 
and the primary palate (Hinrichsen, 1985; Ohbayashi and Eto, 1986; Sperber, 
2002b; Trasler, 1968)(Fig. 2).   Closure of the wide stomodeum results from the 
growth and fusion of the MXPs and the MDPs, which form the corners of the 
embryonic mouth.  Fusion of the MDPs is responsible for the formation of the 
lower lip, mandible and the anterior part of the tongue (Hinrichsen, 1985; Yoon 
et al., 2000).  The bilateral lens placodes are the result of invaginations of the 
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optic placodes and evaginations of the diencephalon.  CNCC migrate around 
these placodes forming the sclera and choroid optic coats as well as the FNP 
(Adler and Canto-Soler, 2007) .  Narrowing of the FNP in conjunction with 
expansion of the lateral areas of the face leads to migration of the eyes towards 
the midline (Sperber, 2002a).  Bones and cartilage of the inner ear are the 
result of migration of CNCC from the first and second branchial arches 
(Gendron-Maguire et al., 1993; Noden, 1983; Rijli et al., 1993). 
3.3.1 Secondary Palate Development 
 Along with the primary palate, the secondary palate acts to form a barrier 
between the oral and nasal chambers.  This separation is an evolutionary 
advancement over the single chamber seen in reptiles and birds (Chong el al., 
2002; Sperber et al., 2002).  Bilateral palate shelves first develop as outgrowths 
from the inner side of maxillary processes at embryonic day 11.5 (E11.5) in 
mice (6th week of gestation in humans), extending along the lateral walls of the 
stomodeal chamber (Fig. 3).  The shelves then grow vertically down either side 
of the tongue until E14.0 (8th week of gestation in humans) (Ferguson, 1988; 
Berkovitz,et al., 2002).  At this point the shelves undergo a rapid elevation to 
become horizontally oriented towards one another above the tongue (Brinkley, 
1980; Ferguson, 1978).  Growth of the stomodeum, as well as functional 
neuromuscular and jaw joint activity makes it possible for the embryo to have 
mouth opening reflexes.  These movements allow the tongue to flatten and 
depress to a point below the edges of the downward positioned palate shelves  
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Figure 3. Schematic Diagram of the Stages of Palatogenesis 
Palate shelves are denoted by the green colour while the tongue is coloured 
red.  Embryonic ages reflect the timing of the events in the developing mouse 
embryo.  Palate shelves arise out of the maxillary prominences (E11.5), they 
grow vertically down the sides of the tongue before elevating above the tongue 
at E14.0 and then contacting one another and fusing.  
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allowing them to reorient (Diewert, 1980; Humphrey, 1969).  The palate shelves 
also undergo a number of changes in order to facilitate the move from a vertical 
position to a horizontal position.  The mechanism of elevation of the palate 
shelves is unclear, some of the predicted mechanisms are: a change in the 
consistency of the palate shelves through an increase in extracellular matrix 
components including hyaluronic acid (Brinkley and Morris-Wiman, 1984; 
Brinkley and Morris-Wiman, 1987; Ferguson, 1978; Larsson et al., 1959; Pratt 
et al., 1973; Singh et al., 1994; Singh et al., 1997), variations in blood flow to the 
palate shelves (Amin et al., 1994), increased cell proliferation and change in 
morphology in specific regions of the mesenchyme  (Babiarz et al., 1979; 
Brinkley, 1980; Brinkley and Bookstein, 1986; Bulleit and Zimmerman, 1985; 
Greene and Pratt, 1976; Greene and Pratt, 1976; Innes, 1978).   The elevated 
palatal shelves then grow towards one another until the medial edge epithelium 
from each shelf contacts to form the midline epithelial seam (MES) at E14.5.  In 
addition to growth of the palate shelves, a change in the relative dimensions of 
the head (vertical dimensions of the head increases while the lateral maxillary 
width remain constant) allows the palate shelves to contact one another at the 
midline (Diewert, 1978; Diewert, 1983).  Epithelial cells from opposing palate 
shelves adhere to one another through glycoproteins on their surface (Greene 
and Kochhar, 1974; Greene and Pratt, 1976; Pratt and Hassell, 1975; Souchon, 
1975) as well as through desmosomes (De Angelis and Nalbandian, 1968; 
Morgan and Pratt, 1977).  Contact of the palate shelves and their subsequent 
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fusion begins in the mid-palate regions and precedes both anteriorly and 
posteriorly like a zipper (Ferguson, 1988; Morgan and Pratt, 1977).  The MES 
then undergoes a rapid degradation to form a secondary palate with complete 
mesenchymal confluence (Berkovitz et al., 2002; Ferguson, 1988). The 
mechanism of midline epithelial seam degradation is still unclear and may 
require any or all of the following: epithelial apoptosis (Farbman, 1968; 
Martinez-Alvarez et al., 2000; Pourtois, 1966; Saunders, 1966; Shuler, 1995; Xu 
et al., 2006), migration (Carette and Ferguson, 1992; Martinez-Alvarez et al., 
2000; Shuler et al., 1992), and epithelial-mesenchymal transformation (Cui et 
al., 2005; Fitchett and Hay, 1989; Griffith and Hay, 1992; Kaartinen et al., 1995; 
Proetzel et al., 1995; Shuler et al., 1992; Sun et al., 1998).  Mesenchymal 
confluence signals the end of palatogenesis at E15.5 (Ferguson, 1988).  In 
addition to fusion to one another, the anterior secondary palate fuses to the 
primary palate and the dorsal portions of the secondary palate fuses with the 
nasal septum (Ferguson, 1988). 
 After the palate shelves have fused, the area undergoes further 
differentiation to form the completed palate.  The dorsal or nasal surface of the 
palate will be lined with ciliated columnar respiratory epithelial cells, while the 
ventral or oral side of the palate will develop stratified squamous epithelial cells 
(Carette et al., 1991).   Anterior and posterior regions of the palate also undergo 
distinct differentiation.  The anterior portion of the palate undergoes ossification 
beginning during the 8th week post fertilization in humans (E14 in mice).  
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Intramembranous ossification begins at primary centers in the maxillae and 
palatine bones and proceeds out centrifugally, eventually creating the entire 
hard palate (Kjaer, 1992; Sildu et al., 1994).  The posterior palate does not 
ossify and is known as the soft palate (Cohen et al., 1993) 
Defects at any step in the developing palate have been shown to result in 
cleft palate.  In addition to problems with development of the palate proper, 
defects in the development of other craniofacial elements including the tongue 
and mandible can result in a cleft palate.  
3.3.1.1 Cleft Palate 
Cleft palate is one of the most common congenital birth defects in the 
human population occurring with a frequency of 1:400 to 1:1000 live births 
(Gorlin et al., 2001).  A cleft secondary palate can occur as an isolated birth 
defect (non-syndromic), in conjunction with a cleft lip or as a part of another 
syndrome (syndromic).   
Altered aesthetics is far from the only problem facing individuals born 
with a cleft secondary palate.  Breathing, eating and speaking are all 
challenging for these individuals.  Numerous surgeries are often required to 
repair the cleft, as well as improve the general aesthetics of these individuals.  
In later years, teeth are regularly absent or their development is altered and 
speaking properly can continue to be an issue.  Recent studies have shown 
numerous other side effects of being born with a cleft palate exist.  Individuals 
with a cleft palate have a significantly shorter lifespan with an increased risk for 
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all major causes of death (Christensen et al., 2004).  Hospitalization for 
psychiatric illness in adults is also increased in these individuals (Christensen 
and Mortensen, 2002).  It has been speculated that there may be a link between 
abnormal facial development and abnormal brain development, which would 
explain the increased incidence of psychiatric illness (Nopoulos et al., 2007).  
This is supported by the finding that problems with signalling during forebrain 
development can lead to craniofacial malformations (Marcucio et al., 2005).  
Clearly the effects of this birth defect are diverse and complex and will require 
intensive research to help understand and treat the range of associated 
problems.   
A number of genetic and environmental factors have been reported to 
play a role in the development of cleft palate.  Normal palate development 
requires a tightly regulated and complex network of interactions within and 
between the epithelium and mesenchyme.  Extensive research into the 
expression and interaction of genes within the developing palate has been 
conducted by researchers but a complete understanding of their regulation is 
unclear (reviewed in Gritli-Linde, 2007; Gritli-Linde, 2008).    
 Cleft palate can occur as a result of defects at numerous stages of 
development including: (1) failure of the palate shelves to form properly; (2) 
failure of the palate shelves to grow together and contact at the midline 
epithelial seam due to altered cell proliferation or apoptosis; (3) failure of the 
contacted palate shelves to fuse and gain mesenchymal confluence; (4) failure 
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of the palate shelves to contact one another due to a physical barrier, such as 
the tongue, obstructing their access to one another (Ferguson, 1987). 
3.4 Molecular Signalling within the Palate 
During mammalian embryogenesis the development of the secondary 
palate is regulated by a complex network of signalling pathways (Fig. 4).  These 
pathways work together to tightly regulate critical cellular processes in the 
palate including: cell proliferation, apoptosis, migration and epithelial-
mesenchymal transdifferentiation.  It has been well reported that there are 
numerous pathways that display reciprocal signalling between the epithelium 
and mesenchyme (reviewed in Gritli-Linde, 2007).  Many genes known to be 
expressed in the palate show specific expression in either the epithelium or 
mesenchyme but their function is in regulating cellular processes in the other 
cell population such that there is to and fro signalling between the epithelium 
and mesenchyme (Nawshad et al., 2007; Rice et al., 2004; Yamamoto et al., 
2003; Zhang et al., 2002).  In recent years, it has become increasingly evident 
that gene expression does not only display epithelial-mesenchymal specificity 
but can also have anterior-posterior or medial-lateral specific expression.  In 
addition to their specifically localized expression, genes have been reported to 
elicit different responses in different regions of the palate.  For example, while 
Fgf10 acts to promote proliferation in the anterior palate it has no affect on 
proliferation in the posterior region of the palate (Rice et al., 2004).  Due to the 
number of genes involved in the development of the palate that display very 
 20 
 21 
Figure 4. Overview of the Signalling Pathways Involved in Regulating 
         Palatogenesis  
Schematic representation of the major signalling pathways known to be 
involved in regulating murine palatogenesis.  Green arrows denote activation, 
while red lines denote repression of one factor on another.  Black lines 
represent the effects of that factor on the denoted process (proliferation or 
fusion), if crossed by red lines the process is inhibited by the factor.   The pink 
area representing the epithelium, grey represents the mesenchyme. Factors are 
shown in their relative anteroposterior region of expression, with factors with an 
exclusively anterior expression pattern in purple, posterior expression indicated 
in yellow.  Expression patterns that are not region specific or are confirmed are 
shown in blue.   
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specific regional expression, it is clear that regional differentiation must be 
occurring within the palate.  Although the morphological differences have long 
been recognized between the different regions of the palate, these localized 
expression and function phenomena clearly highlight the importance of regional 
patterning and differentiation within the palate at the molecular level.   
Regulation of proliferation, apoptosis, fusion, and cell migration has all 
been examined in the palate.  Each of these processes has been shown to be 
controlled by a tightly regulated network of genes including signalling 
molecules, growth factors and transcription factors.  The role of a particular 
gene or signalling pathway can vary depending on the stage of palate 
development and the location within the palate.    It is clear that there is not a 
single straightforward pathway sufficient to regulate palatogenesis; instead an 
intricate regulation takes place between all of these signalling pathways in order 
to ensure palate development occurs normally (Li and Ding, 2007).   
 
3.4.1 Gene Signalling that Regulates Proliferation within the Palate 
3.4.1.1 Msx1 Signalling Pathway 
The first pathway to be described to play a role in regulating proliferation 
within the developing palate involves the homeobox transcription factor Msx1.  
Mutations in the human MSX1 gene have been linked to isolated non-syndromic 
cleft palate (Lidral et al., 1998; Van den Boogaard et al., 2000; Vastardis et al., 
1996).  Msx1 deficient mice display neonatal lethality due to a wide open cleft 
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secondary palate (Houzelstein et al., 1997; Satokata and Maas, 1994).  
Expression of Msx1 is localized exclusively to the anterior mesenchyme during 
the early stages of palate development.  It has been shown to function through 
regulating the expression of Bmp4, Shh, and Bmp2 in the anterior palate.  Msx1 
appears to directly activate Bmp4 expression in the anterior mesenchyme which 
subsequently signals to the epithelium and activates the expression of Shh 
which then signals back to the mesenchyme and activates Bmp2 expression 
(Zhang et al., 2002).  In addition to this pathway, it was also shown that Bmp4 is 
involved in a reciprocal regulatory cycle controlling the expression of Msx1.  The 
main function of Msx1 and its subsequent signalling pathway appears to be in 
regulating cell proliferation within the anterior mesenchyme (Zhang et al., 2002).  
Since this pathway was originally reported, numerous studies have investigated 
the expression and function of the genes in this pathway.  All studies performed 
to date have confirmed that this pathway is important in anterior mesenchyme 
proliferation.  However, they have determined that the regulation of each of 
these genes is far more complex than the original pathway suggested.   
 The regulation of Msx1 expression has been linked to many other factors 
in the palate.  Loss of the Fgf antagonist Spry2 was shown to result in increased 
Msx1 expression as well as a posterior expansion of its expression border.  This 
increased expression led to an increase in proliferation within the palate (Welsh 
et al., 2007).  Msx1 has been shown to be Fgf-responsive in other regions of 
craniofacial development (Alappat et al., 2003; Bei and Maas, 1998).  However, 
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Fgf10 null palates do not display altered Msx1 expression (Alappat et al., 2005).  
These data suggest that other Fgfs are likely acting in the palate to regulate 
Msx1 expression.  It has been proposed Fgf9 may play an active role in palate 
development (Colvin et al., 1999; Colvin et al., 2001) and that loss of Spry2 may 
relieve the antagonism of Fgf9 resulting in the observed upregulated and 
expanded Msx1 expression (Welsh et al., 2007).  Fgf7 has also been shown to 
be expressed within the palate mesenchyme (Rice et al., 2004) and could 
therefore also be involved in regulating Msx1 expression and may be altered by 
loss of Spry2.  
 The transcriptional activity of Msx1 can be altered by other proteins in the 
palate.  Msx1 has been shown to undergo post-translation modification by 
sumoylation in vivo.  This modification was shown to occur in a region of the 
protein which is responsible for regulating interactions between Msx1 and other 
proteins (Gupta and Bei, 2006).  Therefore, sumoylation of Msx1 may help 
control its ability to interact with other transcription factors and therefore 
regulate its ability to regulate the expression of other genes.  Haplosufficiency of 
the SUMO1 gene has been shown to result in cleft palate through altering the 
sumoylation status of various proteins (Eya1, Pax9 and Msx1) in the palate 
(Alkuraya et al., 2006). 
 In addition to regulating Bmp4 and Bmp2, Msx1 has recently been shown 
to regulate the expression of Bmp7.  Loss of Msx1 leads to a decrease in the 
anterior palatal expression of Bmp7, but an increase in its expression in the 
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posterior palate.  The Bmp antagonist Follistatin is primarily expressed in the 
anterior palate in a restricted dorsal domain that does not overlap the regions of 
Bmp4 and Bmp2 expression.  These restricted expression patterns appear to 
be the result of Follistatin repressing Bmp4 and Bmp2 and regulating its region 
of action.  In addition to increased Bmp7 expression, Msx1 null mice also exhibit 
a decrease in the level of Follistatin expression (Levi et al., 2006).  Together, 
these data highlight the important role for Msx1 in the regulation of the Bmp 
family and their antagonists in the palate and provides another mechanism by 
which it may regulate the level of proliferation in the anterior palate. 
 Mutations in the Dlx5 gene have recently been shown to result in a cleft 
secondary palate despite the fact that it does not appear to be expressed within 
the palate proper (Levi et al., 2006).  In addition, loss of the transcription factor 
MEF2C consequently leads to loss of Dlx5 expression in the branchial arches 
resulting in a cleft palate (Verzi et al., 2007).  It is known that despite an 
absence of Dlx5 expression within the palate, Dlx5/Msx1 double knockouts 
show a partial rescue of the Msx1 null cleft palate phenotype.  It appears that 
loss of Dlx5 in Msx1 null embryos alters the expression of Bmp7 and Follistatin 
in the anterior palate in a non-cell autonomous fashion.  These data also show 
that increased Bmp7 and decreased Follistatin in the anterior palate appear to 
be able to compensate for the loss of Bmp4 expression and partially rescue the 
cleft palate phenotype seen in Msx1 null mice, likely through allowing for 
somewhat normal proliferation to take place in the anterior palate (Levi et al., 
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2006).  It is unclear whether Dlx5 plays a role in regulating the growth and 
development of other craniofacial structures which impact palate development.    
3.4.1.2 Bone Morphogenic Protein Signalling Pathways 
Bmp4 has been known to be downstream of Msx1 in the palate for many 
years (Zhang et al., 2002), and as with Msx1, many alternative regulatory 
pathways have been elucidated for Bmp4 in recent years.  The transcription 
factor Tbx3 shows an overlapping expression pattern with Bmp4 in the 
developing anterior palate mesenchyme.  These two genes have been reported 
to regulate each others expression in the palate whereby Tbx3 can act to inhibit 
the expression of Bmp4 while Bmp4 acts by inducing the expression of Tbx3.  
As expected based on the previously reported role of Bmp4 in the palate, this 
regulatory loop acts by regulating the levels of cell proliferation in the anterior 
palatal mesenchyme (Lee et al., 2007).  In the limb, it has previously been 
reported that Tbx3 expression is dependent on Bmp4 (Tumpel et al., 2002) and 
that it plays an important role in maintaining normal proliferation in the region 
(Davenport et al., 2003).  Tbx3 null embryos, however, do not display a cleft 
palate and therefore its ability to repress Bmp4 expression and subsequently 
regulate proliferation may be redundant with another regulatory mechanism in 
the palate.  
 At the initial onset of palate development the transcription factor Tp63 
was found to regulate the expression of Bmp4 in the anterior palate.  Loss of 
the Tp63 gene leads to cleft palate through altering the expression of a variety 
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of genes (including Bmp4) in the maxillary processes from which the palatal 
shelves emanate.  This altered gene expression results in defects of the 
anterior-posterior axis as well as the onset of palate development (Thomason et 
al., 2008).  These results show that regulation of gene expression during and 
prior to the overt growth of the palate shelves can influence palate development 
and patterning.  
 Bmp4 acts upstream of Shh and Bmp2 within the palate (Zhang et al., 
2002).  Recently it was shown that the Wnt5a signalling molecule is involved in 
regulating the anterior-posterior axis in the palate, including the expression of 
Bmp4.  In the absence of the Wnt5a signalling, Bmp4 expression is 
downregulated in the anterior palate while being ectopically upregulated in the 
posterior palate.  As expected, similar changes were observed in the expression 
profile of Shh.  Two interesting findings involving this pathway were also 
reported.  The first is that Bmp2 expression was unaltered in the Wnt5a null 
mutants.  These data implied that Bmp2 expression in the palate must be 
regulated by an alternative mechanism than the one described previously 
(section 3.4.1.1, page 22).  The second finding was that despite a decrease in 
Bmp4 and Shh expression, proliferation was increased in the anterior 
mesenchyme (He et al., 2008).  This once again suggests that the regulation of 
anterior palate development is more complex than initially reported and involves 
the cooperation of multiple signalling pathways.  
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 It has been well recognized that the Bmp family plays an important role in 
maintaining the anterior-posterior axis of the palate shelves as well as 
regulating proliferation.  The Bmp ligands are not the only members of the 
family that are important in palatal development, but they also regulate 
expression and cell processes through binding to cellular receptors.  The Bmp 
receptor Bmpr1a has been reported to be essential in the regulation of 
proliferation and patterning in the palate.  Loss of the Bmpr1a gene leads to 
decreased proliferation as well as an anterior shift in the expression patterns of 
the posterior specific genes Pax9 and Barx1.  The expression of Msx1 was 
unaltered in the Bmpr1a mutants (Liu et al., 2005).   This suggests that other 
Bmp receptors function in the palate which allow for the regulation of Msx1 by 
Bmp4.  Additionally, a novel role for Bmp4 and potentially other Bmps acting 
through the Bmpr1a receptor is to regulate the spatial expression of posterior 
specific genes.   
3.4.1.3 Sonic Hedgehog Signalling Pathway  
 Sonic hedgehog (Shh) is expressed in the epithelium throughout 
palatogenesis.  Expression is restricted to a striped pattern that corresponds to 
the areas of the epithelium that thickened (Rice et al., 2006).  These areas go 
on to form the rugae on the oral surface of the palate.  It has been suggested 
that these rugae act as centers that coordinate patterning within the palate 
(Rice et al., 2004).  This implies an important role for Shh in the patterning of 
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the developing palate.  Shh is a known downstream target of the Msx1 
signalling pathway that has been shown to regulate cell proliferation in the 
anterior palate (Zhang et al., 2002).    
Regulation of the Shh signal is crucial for normal palate development to 
occur.  Loss of the Spry2 gene leads to a disorganization in the expression 
pattern of Shh which ultimately leads to deformities in the rugae of these 
knockout animals (Welsh et al., 2007).  
  Gli3 is a protein shown to be expressed in the epithelium and 
mesenchyme along the entire anterior-posterior axis of the palate, and is 
capable of acting as both an activator and repressor of Shh signalling (Huang et 
al., 2008).  In the absence of the Shh signal, the Gli3 protein is processed by 
protein kinase A allowing it to enter the nucleus and repress the expression of 
Shh target genes.  The presence of the Shh signal prevents the processing of 
the Gli3 protein and therefore, prevents Gli3 from being capable of repressing 
the expression of the Shh target genes (Litingtung et al., 2002; Wang et al., 
2000).    In the limb, the antagonistic relationship between Shh and Gli3 is 
crucial in setting up the anterior- posterior axis.  Gli3 is expressed in the anterior 
region of the developing limb, where it represses the expression of Shh.  
dHAND is a posterior specific protein that in the limb that is also repressed by 
Gli3 but is a known activator of Shh expression.  Together this pathway sets up 
an anterior-posterior axis in the limb that ensures proper development 
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(Niswander, 2003).  The important role of the interaction between Gli3 and Shh 
plays in the limb, in combination with the expression of both genes in the palate, 
suggested that there may be a role for Gli3 in the palate.   It was therefore not 
surprising when Gli3 null mice were found to display a cleft secondary palate.  It 
was however surprising that this cleft palate phenotype does not appear to be 
the result of changes within the palate itself, but rather due to a defective growth 
of the tongue (Huang et al., 2008).  Clearly, these results show that signalling 
pathways are not conserved between areas of the developing embryos. Hence, 
by simply lining up the expression of all of the players in a pathway within the 
palate does not necessarily imply that they function by a similar mechanism 
described in other areas of the developing embryo.   
3.4.1.4 Sprouty2 Signalling Pathway 
In addition to the Bmp family of signalling molecules, the Fgf family plays 
an important role in palate development.  Mutations in numerous members of 
the Fgf family have been shown to be linked to cleft palate in the human 
population (Riley et al., 2007).   Loss of the Fgf antagonist Spry2 leads to a cleft 
palate due to alterations in the level of cell proliferation within the palate, as well 
as the expression profiles of numerous genes including Msx1.  This mutation 
also leads to clear defects in the anterior-posterior patterning of the palate.  The 
posterior expansion of Msx1 coincides with a loss of the anterior expansion of 
the posterior specific transcription factor Tbx22.  While Tbx22 expression fails to 
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reach its normal anterior expression boundary, Etv5 and Barx1 which are 
primarily expressed in the posterior palate expand their domains anteriorly 
(Welsh et al., 2007).   This would suggest that antagonism of Fgfs by Spry2 
affects a number of signalling pathways in the palate leading to gross changes 
in their expression patterns.  Although Fgf signalling is necessary for palate 
development, it appears that its action must be fine-tuned by repressors in order 
for proper palatogenesis to occur. 
3.4.1.5 Barx1 Signalling Pathway 
Barx1 expression has been demonstrated to have a predominantly 
posterior expression profile which is complementary to the anterior expression 
of Msx1.  This region specific expression is initially set up in the branchial 
arches where Msx1 expression is localized to the distal regions of the first 
brachial arch while Barx1 expression is localized proximally (Barlow et al., 
1999).  It is believed that the anterior-posterior axis derived from the region 
expression of Barx1 and Msx1 is the result of the relative strength of Bmp and 
Fgf signalling (Welsh et al., 2007). The expression of Barx1 has been shown to 
be altered in a number of knockout mouse lines.  Loss of Spry2 not only affects 
Msx1 and Tbx22 expression. It also leads to an anterior expansion of Barx1 
expression which is believed to be involved in the increased cell proliferation 
seen in these palates (Welsh et al., 2007).  The loss of the Bmp receptor 
Bmpr1a also led to an expansion of the region in the palate expressing Barx1 
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(Liu et al., 2005).  The fact that alterations in both Fgf and Bmp signalling 
causes altered Barx1 expression supports the theory that regulation of the 
regional expression of Barx1 involves both of the families of signalling 
molecules.   
3.4.1.6 Tbx22 Signalling Pathway   
Tbx22 has also been described to have a posterior specific expression 
profile within the developing palate (Herr et al., 2003).  The Tbx22 gene is a T-
box protein that acts as a transcription factor regulating the expression of 
downstream genes.  It has been reported that alterations in the Tbx22 gene can 
lead to a cleft palate.  This has been identified as the most common single 
cause of cleft palate known to date (Marcano et al., 2004).  It has also been 
shown that a missense mutation in the Tbx22 gene is responsible for X-linked 
cleft palate (Marcano et al., 2004).  The missense mutation in individuals with X-
linked cleft palate has been found to affect the ability of Tbx22 to bind DNA and 
subsequently act as a transcriptional repressor.  It is believed that this mutation 
prevents the SUMO-1 enzyme from sumoylating the Tbx22 protein.  In the 
absence of this post-translational modification, Tbx22 has a much lower affinity 
for its DNA binding sequence (Andreou et al., 2007).  If Tbx22 can not 
recognize and bind to its target binding sequence appropriately it is not possible 
for it to perform its normal repressor functions.  Once again an important role in 
regulating palatogenesis has been assigned to SUMO-1.  Based on the number 
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of important genes known to require sumoylation to function properly, it is not 
surprising that haploinsufficiency of SUMO-1 leads to a cleft palate (Alkuraya et 
al., 2006). 
Tbx22 expression in the Spry2 mutants is significantly restricted in Spry2 
mutants.  In the absence of this Fgf antagonist the expression of Tbx22 failed to 
expand from the most posterior regions of the palate.  This altered expression 
profile coincided with a posterior shift in the expression of Msx1 as well as an 
increase in proliferation throughout the palate shelves (Welsh et al., 2007).  It 
has previously been reported that the 5‟ regulatory region of the Tbx22 gene 
contained putative Msx1 binding sites (Herr et al., 2003).  These data suggest 
that Msx1 is likely involved in repressing the expression of Tbx22 in the anterior 
palate, leading to a posterior specific expression pattern in wild-type palate 
shelves. 
A novel molecular pathway involving the Tbx22 gene was recently 
described (Liu et al., 2008).  Loss of one or both copies of the gene encoding 
the transcription factor Mn1 leads to craniofacial abnormalities including a cleft 
secondary palate.  Mn1 has a medial-posterior specific expression profile that 
generally overlaps the Tbx22 expression profile.  In the Mn1 null embryos the 
expression of the Tbx22 gene was decreased in the posterior region of the 
palate and it was determined that Mn1 directly regulates the expression of 
Tbx22 in the palate.  In addition to a decrease in Tbx22 expression, there was 
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also a marked decrease in proliferation in the medial and posterior palate 
shelves.   However, this is believed to be due, at least in part, to the regulation 
of a separate gene target (Ccnd2) by Mn1 (Liu et al., 2008).  This represents 
the first pathway that specifically regulates the level of proliferation in the 
posterior palate.  Tbx22 expression therefore appears to be regulated by at 
least two factors within the palate.  Msx1 acts as a repressor, while Mn1 acts as 
an activator and together they determine the specific expression domain of 
Tbx22 in the posterior region of the palate.   
3.4.1.7 Fgf10 signalling pathway 
The best understood Fgf-dependent pathway in the palate involves Fgf10 
and its receptor Fgf2rb.  Fgf10 null mice exhibit a wide open cleft palate that 
appears to be due to abnormal palate shelf morphology and size, preventing the 
shelves from contacting at the midline epithelial seam.  In addition, ectopic 
fusion of the palate shelves to the oral epithelium was observed in some 
animals, preventing proper shelf elevation (Alappat et al., 2005).  Similar to 
Msx1 expression, Fgf10 is expressed primarily in the anterior palate 
mesenchyme at the early stages of palatogenesis. The Fgf10 ligand acts 
through the receptor Fgfr2b, which also shows an anterior specific expression 
pattern in areas of epithelium adjacent to mesenchyme expressing Fgf10 
(Alappat et al., 2005; Rice et al., 2004).  Shh expression is downregulated in the 
epithelium of both Fgf10 and Fgfr2b null embryos.   This downregulation directly 
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leads to a severe reduction in epithelial cell proliferation and consequently a thin 
epithelial layer.   Mesenchymal cell proliferation was also significantly 
decreased due to a lack of reciprocal Shh signalling through its receptor Ptc1 
(Alappat et al., 2005; Rice et al., 2004).  Msx1 expression was not altered in 
Fgf10 null mutants (Alappat et al., 2005),  clearly demonstrating that the altered 
Shh expression in the Fgf10 or Fgfr2b null mice is directly due to the loss of Fgf 
signalling, and not through alterations in the Msx1 pathway.  Therefore, like all 
the other members of the Msx1 pathway, Shh expression is regulated by more 
than one mechanism.  Additionally, regulation of cell proliferation in the anterior 
mesenchyme is regulated by this pathway as well as the others discussed.   
Loss of Fgf10 signalling altered other cellular processes including apoptosis 
suggesting it also plays a role in cell survival.  Fgf10 null mice exhibited 
premature and ectopic fusion suggesting it also plays a role in ensuring proper 
fusion (Rice et al., 2004).   
Fgf10 clearly regulates cell proliferation within the anterior palate.  It is 
interesting to note that if the posterior palate is exposed to ectopic Fgf10 there 
is not a noticeable effect on the level of proliferation (Rice et al., 2004).  
Therefore, the downstream effectors of Fgf10 expression must not be present 
within the posterior region of the palate.  This implies that distinct pathways are 
responsible for the regulation of anterior and posterior cell proliferation.     
 
 36 
3.4.1.8 Fgf Receptors      
The Fgf receptor Fgfr1b has also been described to have an anterior and 
medial specific expression pattern within the developing palate.  As with other 
members of the Fgf family, its expression was linked to the regulation of 
proliferation within the anterior palate.  Expression of Fgfr1b was shown to be 
negatively regulated by the Wnt11 signalling molecule.  In return, Fgfr1b was 
shown to negatively regulate the expression of Wnt11.  At early stages of palate 
development the balance is tilted towards Fgfr1b allowing the palate to undergo 
cell proliferation.  As palate development proceeds however, the expression 
balance is shifted away from Fgfr1b.  At this stage it has been shown to be 
important for proliferation to temporarily halt in order for the individual palate 
shelves to fuse and form a complete palate (Lee et al., 2008).  Again, this 
shows that although the most obvious role for the Fgf family is in regulating the 
level of proliferation within the palate it also plays a role in regulating events like 
fusion through maintain low expression of certain genes until the appropriate 
time.      
3.4.1.9 Shox2 Signalling Pathway 
Fgf10 expression has been shown to be downstream of the homeobox 
transcription factor Shox2.    The Shox2 gene is expressed solely in the anterior 
mesenchyme region of the developing secondary palate, with its highest 
expression seen during the early stages of palate development.  When mice are 
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deficient in the Shox2 gene they exhibit a rare form of cleft palate where the 
cleft only occurs in the anterior part of the secondary palate.  In these Shox2 
null mice it was reported that the expression domains of both Fgf10 and Fgfr2c 
were altered.  This altered expression corresponds with a decrease in 
proliferation and increase in apoptosis within the anterior palate (Yu et al., 
2005).  These data show that it is possible that altering the expression of genes 
only in one area of the palate can lead to clefting only in a specific area.   
The regulation of the Shox2 gene has also been investigated.  Although 
a complete understanding of Shox2 regulation is far from being achieved, it was 
shown that blocking Bmp signalling with the antagonist Noggin resulted in a 
downregulation of Shox2 expression within the exposed anterior mesenchyme.  
Exposure of the palatal mesenchyme to Bmp4, Bmp2 and Shh was not 
sufficient to induce Shox2 expression.  These data suggests that while Bmp 
signalling does not appear to be capable of inducing Shox2 expression on its 
own, it is necessary for normal Shox2 gene expression (Yu et al., 2005).    
3.4.2 Regulation of Palatal Shelf Fusion 
 The mechanism by which the palate shelves fuse together to create a 
complete secondary palate has been a matter of dispute for many years.  
Apoptosis (Martinez-Alvarez et al., 2000; Xu et al., 2006), migration (Martinez-
Alvarez et al., 2000), and epithelial-mesenchymal transformation (Cui et al., 
2005; Fitchett and Hay, 1989; Griffith and Hay, 1992; Kaartinen et al., 1995; 
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Proetzel et al., 1995; Shuler et al., 1992; Sun et al., 1998) have all been 
suggested as potential mechanisms.  It is becoming apparent that fusion of the 
palate shelves likely requires a combination of all three of these processes and 
can not be explained by a single mechanism.    
3.4.2.1 Transforming Growth Factors Signalling Pathways 
TGF-β3 has been shown to be essential in the fusion of the palate 
shelves. TGF-β3 null mutant mice exhibit a cleft secondary palate due to failure 
of the elevated palate shelves to adhere and fuse (Fitchett and Hay, 1989; 
Griffith and Hay, 1992; Shuler et al., 1992; Sun et al., 1998). Numerous 
members of the TGF-β family of genes have been shown to be involved in 
several regulatory processes during palatogenesis including: cell migration, 
epithelial-mesenchymal transformation, extracellular matrix synthesis and 
deposition, degradation of the basement membrane, cell proliferation and 
apoptosis (reviewed in Kaartinen et al., 1997; Pelton et al., 1990).  TGF-β3 
expression is first detected at E11.0 in palatal epithelium and remains restricted 
to the epithelium with increasing intensity as development progresses.  At E14 
there is distinct localization of intense TGF-β3 expression to the medial 
epithelial edge, with expression lost only after palatal fusion when the cells lose 
their epithelial phenotype (Fitzpatrick et al., 1990; Pelton et al., 1990).   
 It has been demonstrated fairly convincingly that in the palate, TGF-β3 
signals through Smad-dependent pathways.  TGF-β3 has been shown to act 
through a transmembrane serine/threonine kinase receptor (Tβr) (Cui and 
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Shuler, 2000). Upon binding of TGF-β3 to its receptor, Alk5 is phosphorylated 
and both Alk5 and the receptor-ligand complex are internalized. Smad anchor 
for receptor activation (SARA), a cytoplasmic protein, interacts with Smad 2/3 
and brings it to the internalized activated receptor where Smad 2/3 is 
phosphorylated (Tsukzaki et al., 1998), allowing it to form a complex with 
Smad4 and be translocated to the nucleus where the complex activates 
transcription of genes such as lymphoid enhancer factor 1 (Lef1).  Lef1 has 
been shown to induce midline epithelial seam degradation (Nawshad and Hay, 
2003; Nawshad et al., 2007).  Overexpression of the Smad2 protein in the 
medial epithelial edge of TGF-β3 null mutant mice partially rescues the cleft 
palate phenotype, although fusion was not observed at the junction between the 
primary and secondary palates or at the most posterior region of the secondary 
palate.  These data clearly suggest that although Smad2 phosphorylation is 
critical for proper palate fusion, there are other unknown factors that are 
required in palatal fusion involving TGF-β3 (Cui et al., 2005). 
 A downregulation or absence in the expression of TGF-β3 results in an 
upregulation in the expression of TGF-β1, which consequently leads to ectopic 
activation of Snail (a zinc-finger transcription factor) in the epithelium.  Snail 
activation in the epithelium is known to promote cell survival, therefore inhibiting 
the action of TGF-β3 in degrading the epithelial seam (Martinez-Alvarez et al., 
2004).  TGF-β1's exact role in palatogenesis has been very difficult to decipher 
as embryos die at E11.0, prior to the beginning of palate development (Brunet 
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et al., 1995).  TGF-β1 expression is first detected in the developing murine 
palate at E12.0-12.5 in the epithelium.  TGF-β1 expression continues to be 
localized to the epithelium, both in cells expressing and those not expressing 
TGF-β3 (Fitzpatrick et al., 1990).  Expression remains in the epithelial cells until 
E15.5 when they lose their epithelial phenotype (Fitzpatrick et al., 1990; Pelton 
et al., 1990).  At this stage, a low level of mesenchymal TGF-β1 expression is 
also observed.  Later in development TGF-β1 expression is limited to areas of 
the palate undergoing ossification (Pelton et al., 1990).  TGF-β1 has also been 
described as a potent inducer of apoptosis, and is hypothesized to be 
responsible for the apoptosis observed in the periderm prior to shelf contact.  
Once the periderm has been sloughed off, the underlying layer of medial 
epithelial edge cells that are exposed are able to form the adherent seam 
(Nawshad et al., 2004).   
3.4.2.2 Epidermal Growth Factor Signalling Pathway 
Epidermal growth factor (EGF) has also been shown to play a key role in 
maintaining cell proliferation and survival in the epithelium of the developing 
palate.  EGF signalling must be tightly regulated however, as the medial 
epithelial edge cells must stop DNA synthesis and cell proliferation prior to the 
palate shelves initially contacting one another, and EGF has been shown to 
inhibit these cessations (Yamamoto et al., 2003).  EGF is known to signal 
through binding to and activating its receptor tyrosine kinase (Hackel et al., 
1999). This activation starts a three kinase pathway, whereby Raf, a mitogen-
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activated protein kinase (MAPK) phosphorylates MEK1/2, a MAPK kinase, 
which in turn phosphorylates the MAPK extracellular signal regulated kinase1/2 
(ERK1/2) (Graves et al., 2000; Marshall, 1995).  Upon phosphorylation, ERK1/2 
translocates from the cytoplasm to the nucleus where it acts to phosphorylate 
transcription factors, causing them to become activated and change the 
expression of a variety of target genes involved in cell survival and proliferation 
(Brunet et al., 1999; Khokhlatchev et al., 1998).  Phosphorylated ERK1/2 was 
found to be localized to the medial epithelial edge cells within the palate, with 
none detected within the mesenchyme (Yamamoto et al., 2003).  It is important 
to note that ERK1/2 is the only known target of MEK1/2 (Pearson et al., 2001).  
When palatal organ cultures were grown in the presence of exogenous EGF, an 
increase in DNA synthesis, and therefore cell proliferation was observed.  
These cultures also showed that although the treated palate shelves appear to 
adhere to one another normally, the midline epithelial seam never degraded 
and therefore palate fusion was never complete (Yamamoto et al., 2003).  
When a MEK1/2 specific  inhibitor was introduced into these palate organ 
cultures, the levels of phosphorylated ERK1/2 and DNA synthesis returned to 
normal and the cleft palate phenotype was rescued (Yamamoto et al., 2003).  It 
has also been shown that phosphorylated ERK1/2 can elicit one of two effects 
on cells.  Depending on the location and duration of the activated ERK, this can 
either result in differentiation or proliferation.  It is believed, that retaining the 
phosphorylated ERK1/2 within the cytoplasm is sufficient to block the 
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proliferative effects (Brunet et al., 1999; Formstecher et al., 2001; Tohgo et al., 
2002) and may play a crucial role in the degradation of the medial epithelial 
seam during palatogenesis (Yamamotto et al., 2003).  TGF-β3 has been shown 
to be capable of overriding the proliferative effects of EGF in normal epithelial 
cells (Like and Massague, 1986; Massague, 1990).  It has been hypothesized 
that one of the key roles of TGF-β3 is to prevent the translocation of ERK1/2 to 
the nucleus, preventing its proliferative effects and therefore allowing the fusion 
of the palate shelves through the degradation of the midline epithelial seam, 
although this has yet to be confirmed (Yamamotto et al., 2003). 
3.4.2.3 Meox2 Signalling Pathway 
Meox2 is a homeobox transcription factor shown to have a posterior 
specific expression pattern that becomes increasingly localized to the extreme 
posterior region as development proceeds (Jin and Ding, 2006; Li and Ding, 
2007).  Mice null in the Meox2 gene exhibit a low penetrance of cleft palate that 
results from a novel mechanism.  Palate shelves grow, elevate and fuse, 
however, fusion is weak and as the craniofacial region expands the palate 
shelves pull apart from one another leading to a cleft palate specifically in the 
posterior region.  Histological analysis of the cleft palates showed clearly that 
the palate shelves were completely absent of the medial epithelial edge and 
were composed solely of mesenchyme.  The defect in the palates that is 
responsible for the post-fusion cleft palate is not completely clear.  It may be 
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that there is a palatal growth defect in the posterior palate which prevents the 
palates from being able to keep up with the rest of craniofacial development.  
Alternatively, it may be that loss of Meox2 leads to improper palatal fusion 
leading to a weak seam that does not stand up to the mechanical forces of 
craniofacial development (Jin and Ding, 2006).  Although the role of Meox2 is 
not understood it expression does provide a molecular marker that specifically 
identifies posterior cells within the palate.   
3.4.2.4 Fgf10 Signalling Pathway 
 As discussed in section 3.4.1.7 (pg 34) Fgf10 plays a role in regulating 
proper fusion of the palate shelves.  Loss of the Fgf10 gene leads to ectopic 
fusion of the palate shelves to the oral epithelium in some cases.  This ectopic 
fusion prevents the palate shelves for being able to reorient towards one 
another and therefore leads to a wide open cleft palate (Alappat et al., 2005).  
This shows that the palate shelves must not be able to fuse before they come 
into contact with one another or it can actually be detrimental to proper palate 
development.    
3.4.3 Cell Migration 
 The importance of the migration of cells between regions of the palates 
has become an increasingly interesting phenomenon.  In order for proper palate 
development to occur, it would appear that cells must be able to migrate within 
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the palate.    
Although the expression of Shox2 remains anterior specific throughout 
palatogenesis, it does display a dynamic expression pattern.  At the initial 
stages of palate growth Shox2 expression is only detected in the most extreme 
anterior regions of the palate (less than 25% of the length of the palate).  As the 
palate shelves continue to grow the expression of Shox2 expands until by E14.5 
when it covers the entire anterior palate and most of the medial palate (60% of 
the length of the palate shelf).  Concurrent with the expansion of Shox2 
expression, the region of the palate expressing the posterior specific gene 
Meox2 was shown to shrink (Li and Ding, 2007).  This phenomenon clearly 
shows that in order for the anterior palate to develop properly it must recruit 
cells from the posterior, which are converted into Shox2 anterior specific cells.  
Initially, this was predicted to be due to a repression of Meox2 by Shox2 or a 
downstream target of the Shox2 signalling pathway (Li and Ding, 2007).   
Ror2 has been shown to regulate the expression of Wnt5a in anterior 
specific cells.  The Wnt5a signal was shown to consequently act as a 
chemoattractant causing cells to migrate from the posterior region of the palate 
towards the anterior region.  As discussed above, Wnt5a also was shown to 
regulate the expression of Bmp4 and Shh both of which play important roles in 
the development and growth of the anterior palate (He et al., 2008).  It is 
therefore possible that it is not that Shox2 is simply being upregulated and 
 45 
Meox2 downregulated that results in the conversion of posterior cells to anterior 
cells, but rather that the cells are migrating towards the higher Wnt5a signal.  As 
cells enter the anterior region of the palate, Wnt5a and potentially other factors 
act to alter the expression profile of genes in the cells causing them to 
transdifferentiate into anterior specific palate cells.  
 Recently, it was shown that in addition to regulating proliferation, 
apoptosis and fusion, Fgf10 can also induce cell migration within the anterior 
palate.  Fgf10 expression is not only localized to the anterior mesenchyme but it 
also exhibits higher expression in the lateral region of the anterior mesenchyme 
(Rice et al., 2004).   Fgf10 has been shown to act as a chemoattractant in other 
cell types, and recently was shown to be able to induce the migration of anterior 
mesenchyme cells from the medial to the lateral side of the palate (He et al., 
2008).  The loss of Fgf10 was shown to cause palate shelves that are abnormal 
in shape (Alappat et al., 2005), which could be explained in part by the loss of 
lateral cell migration.  
The new discoveries that cells migrate first from the posterior region of 
the palate to the anterior region of the palate, and then to the lateral region of 
the anterior palate underscores the dynamic processes directing palatal 
development.   Although cells  display a specific set of genes at any time that 
determine how they react to external stimuli, that set of factors is continually 
changing as development proceeds.  Additionally, this migration to the anterior 
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region of the palate specifically lends further support to the theory that the 
anterior palate plays a role as a signalling center acting to regulate 
palatogenesis as a whole.  This also demonstrates the importance of 
maintaining the proper anterior to posterior axis in the palate.   
3.5 Homeobox Genes 
 Homeobox genes (Hox) genes were first described in Drosophila 
(Balkaschina, 1929; Bridges and Morgan, 1923; Bridges and Dobzhansky, 
1933).  This group of genes was of particular interest due to their ability to 
transform each segment of the body into the likeness of another. In Drosophila, 
these homeotic genes are localized on a single chromosome (chromosome #3) 
into a homeotic complex (HOM-C), which is separated into two separate 
clusters [Bithorax complex and Antennapedia complex] (Kaufman et al., 1990; 
Lewis, 1978; Scott et al., 1983).  Homeobox genes are evolutionarily conserved, 
and found in all metazoans, plants and fungi examined to date (Burglin, 1997).  
Vertebrates express homeobox genes that share a high degree of sequence 
similarity to those in the Drosophila that play important roles in embryonic 
patterning and development (reviewed in Akin and Nazarali, 2005).  
There are over 700 homeobox-containing genes identified to date in 
vertebrates (Zhong et al., 2008).  A subset of these genes are called „clustered‟ 
genes and are known as Hox genes.  A common feature between the 
Antennapedia-class genes and Hox genes is a 180 base pair homeobox 
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Figure 5.  Schematic Diagram of the Homeodomain 
Schematic representation of the interaction between the homeodomain 
of a Hox protein and DNA.  The third helix (purple) acts as the recognition helix 
and interacts with the major groove of DNA.  The fourth helix (yellow) acts as an 
extension of the third.  The first (red) and second (green) helices interact with 
the DNA backbone to stabilize the interaction. The region N-terminal to the first 
helix allows the protein to interact with other protein cofactors. 
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sequence that encodes a 60 amino acid protein domain called the 
homeodomain.  Four alpha helices are the core of this domain (Fig. 5).  The first 
three alpha helices form a compact globular structure, while the fourth helix is 
more flexible and appears to be an extension of the third helix.  N-terminal to 
the first helix, is a conserved flexible region of six amino acids that acts by 
allowing the Hox protein to interact with other protein co-factors.  The second 
and third helices together form a helix-turn-helix motif that is capable of 
recognizing and binding to a specific sequence of nucleotides on DNA, 
providing them the ability to act as transcription factors and regulate the 
expression of downstream genes (Akin and Nazarali, 2005; Gehring et al., 
1990; Graba et al., 1997; Kissinger et al., 1990; Li et al., 1990).  The third helix 
is the recognition helix, which contacts the target DNA in the major groove.  The 
first and second helices also make contact with the DNA backbone in order to 
stabilize the structure.  A core binding site for Hox genes has been determined 
in vitro and consists of a 10-12 base pair regions with a core sequence of TAAT 
(Gehring et al., 1990; Kalionis and O'Farrell, 1993; Laughton, 1991).   
  In mice and humans there are 4 separate chromosomal Hox gene 
clusters called the HoxA, HoxB, HoxC and HoxD.  In total there are 39 genes in 
these Hox clusters in mice and humans.  Each cluster is arranged in a 3′ to 5′ 
order, which also reflects their homology to genes in the other Hox clusters as 
well as their level of similarity with the genes in the HOM-C complex in 
Drosophila.  Each of the clusters contains multiple genes numbered based on 
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their linear position in the chromosomal cluster as well as their similarity to the 
HOM-C complex.  There are 13 paralogous gene groups in mice and humans 
(Fig. 6).  Paralogs exhibit a higher degree of sequence similarity with each other 
than with any of the genes in their cluster.  Although there are 13 groups, none 
of the clusters actually contain genes in all 13 paralogous groups.  Genes within 
each cluster exhibit spatial colinearity, that is they are expressed along the 
anterior-posterior axis of the embryo in the same order they appear along the 
chromosome, from the 3´ to 5´ (Dressler and Gruss, 1989; Duboule and Morata, 
1994; Graham et al., 1989; Lewis, 1978).  In general, there is also temporal 
colinearity of the gene clusters with the 3′ genes being expressed earlier in 
development than their more 5′ counterparts (Gaunt and Strachan, 1996; 
Izpisua-Belmonte et al., 1991) (Fig. 6).  Spatial and temporal colinearity does 
not exist between the different chromosomal clusters.  Paralogs are generally 
expressed in the same region and time frame in development suggesting that 
they may be functionally redundant (Gaunt et al., 1989; Manley and Capecchi, 
1998; Rossel and Capecchi, 1999). 
 The Hoxa2 gene is an exception to the spatial colinearity observed 
between of Hox genes.  The anterior expression boundary of Hoxa2 is the 
border between r1/r2.  This is anterior to the Hoxa1 expression boundary, which 
is only present in r4 and more posterior rhombomeres (Prince and Lumsden, 
1994).     
Expression of Hox genes is known to be fundamental in embryonic 
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Figure 6. Organization of Hox Genes Along the Chromosome in the Fruit 
Fly and Mouse as well as their Relative Region of Expression during 
Embryogenesis 
There is a clear conservation of the organization of the HOM-C complex in the 
fruit fly and the four gene clusters in mice.  Paralogous groups share the same 
relative location along the cluster and expression pattern in the body.  Spatial 
colinearity exists between members of the Hox clusters.  The anterior-posterior 
expression of genes occurs from 3‟-5‟ on the chromosome of both the mouse 
and fruit fly. 
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development, and in particular in patterning the body axis. Therefore, functional 
redundancy may act as a safeguard against developmental problems.  Many 
Hox genes act as selector genes, controlling a cascade of events through 
“realizator” genes that is capable of determining the fate of an entire body 
segment.  
3.5.1 Hoxa2 
Hoxa2 belongs to the Hox A cluster of genes in both the mouse and 
human.  The gene was originally cloned in 1992, and designated as Hoxa1.11 
(Nazarali et al., 1992).  The Hoxa2 gene encodes a 41 kDa protein (Tan et al., 
1992), which has been shown to act as a transcription factor in the murine 
central nervous system (Gendron-Maguire et al., 1993; Nazarali et al., 1992; 
Rijli et al., 1993; Tan et al., 1992).  Hoxa2 is the most anteriorly expressed Hox 
gene (Gendron-Maguire et al.,1993; Nazarali et al., 1992; Rijli et al., 1993; Tan 
et al., 1992),  and has been shown to act as the selector gene for second 
branchial arch patterning (Grammatopoulos et al., 2000; Hunter and Prince, 
2002; Pasqualetti et al., 2000; Santagati et al., 2005).  The rostral expression 
boundary of Hoxa2 in the hindbrain is the rhombomere 1/2 boundary (Nonchev 
et al., 1996; Prince and Lumsden, 1994).  Expression is detected as early as 
E8.25 in the neural folds of mice (Maconochie et al., 1999; Nonchev et al., 
1996).  As the CNCC migrate from the rhombomeres into the branchial arches, 
Hoxa2 is not expressed within the migrating CNCC of rhombomeres 2 and 3.  
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Therefore, the first branchial arch is free of Hox gene expression, while the 
more posterior arches express subsets of Hox genes which determine their 
developmental fates (Prince and Lumsden, 1994).  Expression is also detected 
at E12.5 and E14 in the hindbrain, spinal cord, dorsal root ganglia, larynx, 
lungs, vertebrae, sternum, intestine and palate. Later in development Hoxa2 
expression is turned on in the diencephalon and forebrain (Tan et al., 1992; 
Wolf et al., 2001).  
3.5.1.1 Regulation of Hoxa2 Expression 
 The importance of Hox gene expression in patterning the body, and in 
particular the expression of Hoxa2, the selector of the second pharyngeal arch, 
has led to an interest in the genes responsible for regulating the expression of 
this group.  Due to the intricate temporal and spatial regulation of Hoxa2 in 
multiple cells types, it is clear that regulation of Hoxa2 expression is likely to 
involve a network of regulatory elements. Hoxa2 being the sole Hox gene 
expressed within rhombomere 2 led researchers to examine if a unique 
regulatory element exists within the Hoxa2 gene which acts to allow expression.  
A cis-regulatory module, embedded in the second coding exon of Hoxa2, was 
located that allowed expression in rhombomere 2.  This module is a conserved 
enhancer sequence that contains 2 consensus Sox binding sites, as well as 
several other elements, that act together to regulate expression (Tumpel et al., 
2002; Tumpel et al., 2007).  Interestingly, Sox1, Sox2 and Sox3 all exhibit high 
levels of expression in rhombomeres 2 and 4 (Wood and Episkopou, 1999). 
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 Elements that are responsible for regulating the expression of Hoxa2 
within NCC specifically have also been identified.  A region located 5′ to the 
gene contains multiple cis-acting elements were described that work in 
conjunction with one another to regulate Hoxa2 expression in NCC and restrict 
its expression to the cells of the second branchial arch as well as more posterior 
arches.  Although these elements are known to be critical for regulation, it is not 
clear what factors are binding.  One of the elements was shown to bind to 
members of the AP-2 family of transcription factors (Maconochie et al., 1999).  
 In rhombomere 4, it was shown that the regulatory element responsible 
for Hoxa2 expression is located in the first intron of the gene.  This region 
contains 4 separate binding sites, that based on their sequences, are bound by 
Hox-genes as well as their cofactors in coordination with the transcription 
factors Pbx and Prep/Meis.  It was also shown that this regulatory element 
allows Hoxa2 expression to be responsive to Hoxb1.  This confirms that there is 
a regulatory network that exists between the Hox genes and is likely 
responsible for maintaining the proper expression of the correct Hox genes at 
the right anteroposterior regions of the embryo ensuring proper development 
(Tumpel et al., 2007).   
   Krox-20 is a transcription factor that has been shown to regulate the 
expression of both Hoxa2 and its paralog Hoxb2.  The 5′ flanking region of the 
Hoxa2 gene has an enhancer region that is responsible for the expression of 
Hoxa2 in the third and fifth rhombomeres.  This enhancer site has two binding 
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sites for Krox-20.  In Krox-20 null mice there is a complete loss of Hoxa2 
expression in the rhombomere 3.  Hence, different areas of Hoxa2 expression 
are regulated by different mechanisms.  Krox-20 regulates Hoxa2 expression 
within the cells of rhombomeres 3 and 5, but not in the migrating NCC or 
mesoderm (Nonchev et al., 1996).  These data also provide support to the 
theory that there are common elements that regulate different members of the 
Hox gene family.     
3.5.1.2 Hoxa2 Mutant Phenotypes 
Mice lacking Hoxa2 expression in the NCC that have migrated to the 
second branchial arch display a homeotic transformation of the second 
branchial arch hyoid structures to mandibular arch skeletal derivatives of the 
first branchial arch (Gendron-Maguire et al., 1993; Rijli et al., 1993; Santagati et 
al., 2005).  This transformation results in numerous craniofacial abnormalities, 
leading to postnatal mortality within 24 hours of birth.  One of the numerous 
facial abnormalities Hoxa2 null embryos exhibit is a cleft secondary palate in 
81-82% of embryos (Gendron-Maguire et al., 1993; Rijli et al., 1993; Barrow and 
Cappechi, 1999).  Cleft palate leads to problems with feeding for these 
embryos.  Small amounts of milk, along with large amounts of air, were found in 
the abdomen of these animals suggesting that they started to feed postnatally, 
but could not continue due to the build up of air resulting from a lack of 
separation in the oral and nasal cavities (Gendron-Maguire et al., 1993).  During 
normal embryonic development, the first branchial arch gives rise to Meckel‟s 
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cartilage which goes on to form the malleus and incus (first two bones of the 
middle ear).  The second branchial arch cells form Reichert‟s cartilage which 
goes on to form the stapes (third bone of the middle ear), styloid process of the 
temporal bone and the lesser horn and superior portion of the hyoid bone 
(Noden, 1983).  Hoxa2 null embryos display a complete lack of the Reichert‟s 
cartilage derivatives and a duplication of the primordial of the malleus and incus 
(Gendron-Maguire et al., 1993).   Embryos that lack both Hoxa2 and Hoxa1 
actually display a decreased penetrance of cleft palate which was explained by 
the authors as a restoration of the tongue musculature in the double knockouts, 
allowing the tongue to flatten normally (Barrow and Capecchi, 1999). 
Overexpression of the Hoxa2 gene in the first branchial arch of chicks 
leads to a transformation of first branchial arch structures (Meckel‟s cartilage, 
quadrate and entoglossum) into structures from the second branchial arch 
(basihyoid skeleton).  This results in duplication of a number of second arch 
structures, with these duplicate structures being fused to their normally 
occurring counterparts (Grammatopoulos et al., 2000).   
Loss of Hoxa2 exclusively from the CNCC and not the overlying 
epithelium of the second branchial arch was shown sufficient to yield to 
knockout phenotype.  This would suggest that Hoxa2 expression in the 
epithelium alone is not capable of directing the developmental fate of the 
second arch (Santagati et al., 2005).  Conversely, Hoxa2 was also shown to be 
required in both the CNCC and the surrounding tissue to get the complete 
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duplication of the first arch structures into second arch structures.  CNCC 
overexpression of Hoxa2 alone resulted only in a loss of first arch structures.  
Therefore, although the CNCC contain a portion of the required patterning 
information they require cues from the overlying epithelium to develop normally. 
However, expression within the surrounding tissue is not sufficient for 
development.   Also demonstrated with this finding was the fact that the role of 
Hoxa2 is relatively late in development, controlling the differentiation of cartilage 
and not the migration of CNCC (Grammatopoulos et al., 2000). 
3.5.1.3 Hoxa2’s involvement in Palate Development 
The palate is a derivative of the first branchial arch, which is known to 
lack Hox gene expression.  As the NCC migrate into the branchial arches 
Hoxa2 is absent from the cells of the first branchial arch (Prince and Lumsden, 
1994), suggesting that it could not play a direct role in the cleft secondary palate 
in the Hoxa2 null mice.  This led to the original hypothesis that the cleft 
secondary palate was the result of alterations in the hyoid structure, leading to a 
defect in tongue musculature. This defect was believed to cause the tongue to 
act as a physical barrier between the palate shelves, preventing them from 
contacting and fusing (Barrow and Capecchi, 1999).   The recent discovery of 
Hoxa2 expression within the developing palate suggests a more direct role in 
palatogenesis (Nazarali et al., 2000).   Hoxa2 expression is first detectable by 
immunohistochemical analysis at E12 within the palate epithelium.  Expression 
levels continue to increase expanding to include the mesenchyme at E13, 
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reaching its peak at E13.5.  At E14 Hoxa2 expression becomes localized to the 
medial edge epithelium, and remains localized to the epithelium at E14.5 before 
expression is downregulated (Nazarali et al., 2000).   
Whole palate organ cultures grown in the absence of the tongue showed 
a shorter palate length, and a significantly lower fusion rate (44%)  in the Hoxa2 
null mutant embryos than in its heterozygous or wild-type counterparts (78% 
and 90%, respectively) (Zhang, 2003).  In addition, data collected from retroviral 
infection of whole organ palate cultures with anti-sense Hoxa2 showed a 
decrease in fusion rates compared to the control infections (Wang, 2006).  
Together, these data provide strong support that Hoxa2 plays a critical role in 
regulating palatogenesis without completely negating the importance of the 
abnormal positioning of the tongue.  The first step in confirming the role of 
Hoxa2 in palatogenesis is to determine which processes of palatogenesis (i.e. 
cell proliferation, apoptosis and/or fusion), if any, are altered in the absence of 
Hoxa2. Once this information is collected, the search for downstream targets of 
Hoxa2 in the palate can be focused towards those genes known to be involved 
in that aspect of palate development. 
3.5.1.4 Putative Downstream Targets of Hoxa2 in Palate Development 
3.5.1.4.1 Msx1 
Hoxa2 has recently been reported to be upstream of Msx1 in the murine 
second branchial arch neural crest cells.  Wild-type mice show broad Msx1 
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expression in the second arch hyoid structures, and less intensely in the 
mandibular arch, or first arch at E10.5.  Expression was greatly reduced in the 
second branchial arch of Hoxa2 null mice taking on a first arch-like pattern of 
expression (Santagati et al., 2005).  Due to the importance of Msx1 in regulating 
normal proliferation within the developing palate, and the effect Hoxa2 has on 
its expression in the branchial arches, it is an attractive putative downstream 
target of Hoxa2 in the developing palate. 
3.5.1.4.2 Htra3 
The high temperature requirement A3 (Htra3) protein has recently been 
described to be capable of binding to and inactivating a number of members of 
the TGF-β family including: TGF-β1, TGF-β2, Bmp4 and Bmp2. TGF-β3 was 
not tested, and therefore the ability of Htra3 to inhibit its action is still unknown.   
Although the mechanism of this inactivation remains unknown, protease activity 
is an absolute requirement (Tocharus et al., 2004).  Htra3 is an extracellular 
protein, whose primary targets are hypothesized to be extracellular matrix 
proteoglycans, including decorin and biglycan (Tocharus et al., 2004). The 
breakdown and remodeling of the extracellular matrix is known to be a crucial 
part of many embryonic development processes. Htra3 may also inhibit TGF-β 
signalling through its degradation of the extracellular matrix.   
Htra3 has been shown to be a putative downstream target of Hoxa2 in 
the murine spinal cord and hindbrain (Akin, 2004).  Data showed that Hoxa2 
protein bound specifically to a region of the Htra3 genomic sequence in vivo.  A 
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significant upregulation in the expression of Htra3 in the Hoxa2 null embryos 
was also observed (Akin, 2004), suggesting Hoxa2 acts as a direct inhibitor of 
Htra3 expression in the spinal cord and hindbrain.  These data, together with 
the ability of Htra3 to degrade numerous genes important in palatogenesis, 
make Htra3 a possible downstream target of Hoxa2 in the developing palate.   
3.5.1.4.3 Six2 
 Six2 is a homeodomain containing transcription factor that has been 
shown to be involved in regulating craniofacial and kidney development 
(Fogelgren et al., 2008; Fogelgren et al., 2009; Lozanoff, 1993; Lozanoff et al., 
2001; Ma and Lozanoff, 1996; Ma and Lozanoff, 1999; McBratney et al., 2003; 
Singh et al., 1998).  Six2 expression has been reported in the mesenchyme of 
the nasal prominences of E11.5 mice (Brodbeck et al., 2004; Fogelgren et al., 
2008; Ohto et al., 1998; Oliver et al., 1995).  The Brachyrrhine mutation in mice 
was recently shown to involve the abnormal expression of Six2 in both the 
kidney and the developing craniofacial region (Fogelgren et al., 2008).  This 
mutation had previously been described to also result in the absence of the 
primary and secondary palates (McBratney et al., 2003; Singh et al., 1998).  
Interestingly, a Six2 knockout mouse was generated and reported to have 
similar kidney defects as the Brachyrrhine mutation, but did not exhibit any 
craniofacial defects (Self et al., 2006).   At present, it is unclear what role if any 
Six2 does play in the development of the face and in particular in the palate.    
 Six2 has been shown to be a direct downstream target of Hoxa2 in the 
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murine branchial arches (Kutejova et al., 2005; Kutejova et al., 2008).  
Expression of Six2 in wild-type embryos is restricted to the first branchial arch 
mesenchyme.  In Hoxa2 null mice, Six2 expression expands to include the 
second branchial arch.  This suggests that Hoxa2 expression is sufficient to 
repress the expression of Six2 (Santagati et al., 2005).  Interestingly, when Six2 
is overexpressed in the areas of the embryo controlled by Hoxa2 the result is a 
phenotype similar to the Hoxa2 mutant phenotype.  Analysis of the promoter 
region of Six2 in combination with ChIP experiments suggests that Hoxa2 
directly represses the expression of Six2 (Kutejova et al., 2005; Kutejova et al., 
2008).  These findings imply that Six2 may be an important in vivo downstream 
target of Hoxa2, although its role in palate development has not been identified.  
3.5.1.4.4 Ptx1 
Ptx1 is a homeodomain containing transcription factor belonging to the 
paired family.  In the developing mouse, Ptx1 is expressed in the first branchial 
arch as early as E9.0 (Bobola et al., 2003), with all derivatives of the first arch 
including the palate continuing to express Ptx1 until E15.5 (Lanctot et al., 1997).    
Ptx1 expression is expanded to include the second branchial arch mesenchyme 
in Hoxa2 null mice.  In addition, transgenic Hoxa2 expression in the first 
branchial arch is sufficient to block Ptx1 expression.  A partial reversion to the 
wild-type phenotype was observed in double mutants lacking both Hoxa2 and 
Ptx1.  These data suggest that Hoxa2 plays a crucial role in inhibiting Ptx1 
expression in the second branchial arch.  Ptx1 appears to be an important 
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downstream target of Hoxa2, and therefore a good candidate for further 
investigation within the developing palate. 
Mesenchymal expression of Ptx1 in the first branchial arch requires 
fibroblast growth factor 8 (Fgf8) signals from the epithelium.  Removal of the 
epithelium from cultured first branchial arches of wild-type embryos or the 
second branchial arches of Hoxa2 null embryos in vitro results in a complete 
loss of mesenchymal Ptx1 expression.  Expression can be rescued by 
introducing Fgf8 soaked beads to the culture. Lhx6, another Fgf8 target in the 
first branchial arch was also shown in Hoxa2 null embryos to exhibit ectopic 
expression in the second branchial arch (Bobola et al., 2003).   Although Fgf8 
does not show an altered expression pattern in the second branchial arch of 
Hoxa2 null embryos, these data suggest that Hoxa2 regulates the expression of 
Ptx1 and Lhx6 through Fgf8.    
3.6 Summary 
 The development of the secondary palate involves a complex interaction 
of different signalling networks.  The expression and roles of numerous genes 
has been described in recent years.  Despite all of this knowledge a complete 
understanding of palate development is still far from clear.   
 The Hoxa2 gene has previously been shown to be expressed within the 
palate, and loss of expression leads to a high penetrance of cleft palate in 
embryos.  Furthermore, whole organ culture data suggests an increased 
 64 
incidence of cleft palate in Hoxa2 null palates grown in the absence of the 
tongue (Zhang, 2003).  Together, these data suggest a direct role for Hoxa2 in 
regulating palatogenesis; however what that role may be has not been 
investigated.   The purpose of my thesis is to examine the expression and 
function of Hoxa2 in the palate.  In order to elucidate its role, I will investigate 
cell proliferation, apoptosis and fusion of the palate shelves.  In addition, the 
expression of putative downstream targets will be compared between wild-type 
and Hoxa2 null palate shelves throughout development to determine if loss of 
the gene leads to altered expression.  Together, these data will provide us with 
an understanding of the role of Hoxa2 in palate development.  
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4. Materials and Methods 
4.1 Hoxa2 transgenic mice 
 Hoxa2 +/+, Hoxa2+/- and Hoxa2 -/- C57 black mice (Gendron-Maguire et 
al., 1993) were obtained by timed heterozygous matings. Heterozygous animals 
were obtained by backcrossing heterozygous males with wild-type females.  
After pups were weaned, animals were anaesthesized and an approximately 1 
cm piece of the tail was docked.  Genotypes were confirmed by polymerase 
chain reaction (PCR) analyses.  Timed heterozygous matings were then 
performed, and were staged according to Kaufman with mice being considered 
E0 days pregnant on the day the vaginal plug was found (Kaufman, 1992).  
4.1.1 PCR analysis of genotype   
Tissue sample (tail or embryonic tissue) was digested overnight at 55°C 
in a 50mM Tris (pH 8.0), 100 mM EDTA, and 0.5% SDS solution containing 150 
μg of proteinase K enzyme.   Following the digestion, an equal volume of 
phenol/chloroform/ isolamyl alcohol (25:24:1) solution (Sigma) was added and 
the reactions were mixed vigorously to mix the phases completely before 
centrifugation for 10 min at max speed.  The aqueous layer was transferred to a 
fresh tube and the phenol/chloroform/isoamyl alcohol and centrifugation steps 
were repeated.  DNA was then precipitated using 100% ethanol containing 300 
mM sodium acetate.  Samples were washed with 70% ethanol and the DNA 
pellet was allowed to dry to remove any residual ethanol before being dissolved 
in sterile water.  DNA was then analyzed by PCR to determine the genotype of 
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the animal.  Each sample was amplified in two different PCR reactions, one to 
determine the presence of the wild-type Hoxa2 allele (5´-
GTTGGAACTGACCTCCTCTTG-3´ and 5´-GGGTCCGAGCAGGGTTATTCC-
3´) and the other to detect the presence of the neomycin cassette that  replaces 
part of exon 1, all of intron 1 and part of exon 2 in the knockout animals (5´-
TCGCCTTCTATCGCCTTCTTG-3´ and 5´-GTTGGTGTACGCGGTTCTCAG-
3´).  100 μl PCR reactions containing 1X amplification buffer (VWR), 2 mM 
dNTP mix (Sigma), 1μM of each primer (Invitrogen) and 2.5 U of taq (VWR) and 
1 μg of DNA  (VWR).  Reactions were run on the BioRad MyCyclerTM using the 
temperature cycling conditions 95°C for 4 min followed by 35 cycles of 95°C for 
30 s, 65°C for 3 min and 72°C for 7 min (Gendron-Maguire et al., 1993).  PCR 
samples were then separated on a 1% agarose gel containing ethidium bromide 
and visualized using UV light.  A sample of the PCR products is shown in figure 
7.    
4.2 Immunohistochemical analysis 
4.2.1 Fgf8, Six2 and Active Caspase 3 
 Embryos were harvested from timed-pregnant mice, and heads were 
fixed in 4% paraformaldehyde in phosphate buffered saline (PBS).  Embryo 
heads were then placed in 20% sucrose in PBS for at least 24 h before being 
embedded in optimal cutting temperature (OCT) compound (Tissue-Tek) and 
serially sectioned on to gelatin coated coverslips.  Determination of anterior, 
medial and posterior was performed by matching to sections from each region  
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Figure 7.  Sample of the Genotyping Results of Hoxa2 Transgenic Mice 
An ethidium bromide gel of the PCR analysis used in the genotyping of Hoxa2 
transgenic mice.  The presence of a band with the wild-type primers only (first 
well) confirms that the animal is wild-type.  If a band is present only with the 
neomycin primers (second well) this confirms the embryo is Hoxa2 null.  
Presence of both bands indicates that the animal is a heterozygote.  
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in Rice et al 2004 paper.  Sections were then allowed to dry at room 
temperature for at least 2 h.   The 8 μm thick sections were then rehydrated with 
two 20 min washes in PBS and blocked in 3% skim milk powder and 1% Triton 
X-100 in PBS (3% SM-PBST) for 1h. Sections were exposed to the primary 
antibody diluted in 3% SM-PBST overnight at 4°C. Fgf8 was stained using a 
mouse monoclonal antibody (R&D, 1:200),   Six2 was stained with a rabbit 
polyclonal antibody (Affinity BioReagents,1:200) and activated caspase 3 was 
stained with a rabbit polyclonal antibody (R&D, 1:500).  Excess unbound 
primary antibody was rinsed off by two washes in PBS before being exposed to 
labeled secondary IgG Alexa 594 antibody (1:400, Invitrogen) for 45 min at 
room temperature.  Sections were then rinsed twice in PBS before being 
exposed to Hoechst (a fluorescent stain that labels all nuclei).  Finally, sections 
were rinsed two more times in PBS, mounted in Prolong (Molecular Probes) 
and viewed by fluorescence microscopy.  To ensure that the signal observed 
was not the result of non-specific signal from the secondary antibody, negative 
controls were performed.  These included staining in the absence of the primary 
antibody, and another set where the secondary antibody was omitted. 
4.2.2 Htra3 and Hoxa2  
Time staged embryos were fixed in 4% paraformaldehyde followed by 
immersion in 20% sucrose in PBS.  Frozen embryos in embedding medium 
were sectioned (8 m thick), and tissue sections were collected on gelatin-
coated coverslips.  The coverslips were dried for 2h at room temperature before 
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being subjected to immunohistochemical analysis with the TSATM #22 
(Invitrogen) using the following modified procedure.  Coverslips with the tissue 
sections were incubated twice in PBS, 5 min each time, followed by a 1 h 
incubation in a 3% hydrogen peroxide solution. This was followed by two 5 min 
washes in PBS and then 30 min in the manufacturer provided block solution.  
After blocking, sections were incubated overnight at 4°C with the antigen 
specific primary antibody. The Hoxa2 rabbit polyclonal antibody that was 
generated using oligopeptide, SPLTSNEKNLKHFQHQS (Hao et al., 1999; 
Nazarali et al., 2000) was used at a dilution of 1:5000 in the block solution. 
Htra3 staining was stained with a polyclonal rabbit antibody at 1:500 dilution 
(Tocharus et al., 2004).  Sections were rinsed in PBS twice (5 min each) and 
then incubated in biotinylated anti-rabbit secondary antibody (Vector 
Laboratories) at 1:100 for 1 h at room temperature.  Sections were then washed 
twice (5 min each) in PBS, followed by a 30 min incubation in the secondary 
avidin–horseradish peroxidase antibody at 1:100 dilution. The sections were 
washed twice in PBS for 5 min each and then incubated in the Alexa Fluor® 
488-conjugated tyramide diluted to 1:200 in the amplification buffer for 10 min 
and then counterstained with Hoechst before being mounted in Prolong® 
(Molecular Probes). 
4.3 Cell Proliferation Assay 
 Cell proliferation was assessed by intraperitoneal injection of timed 
pregnant mice with 5-Bromo-2'-deoxyuridine (BrdU) at a concentration of 100 
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mg/kg body weight.  BrdU is a thymidine analogue that is taken up and 
incorporated into the DNA of proliferating cells, including those in the 
developing embryos.  One and a half hours after injection, mice were sacrificed 
and the harvested embryos fixed and sectioned as described above.  Tissue 
samples were taken from the body of each embryo and DNA was isolated and 
subjected to PCR analysis as outlined above.  Wild-type and Hoxa2 null 
embryos from the same mother were treated together to minimize variations.  
Sections were immunohistochemically stained with a monoclonal anti-BrdU 
antibody (Sigma) and the Mouse-on-Mouse staining kit (Vector Laboratories) to 
detect proliferating cells, using a modified procedure as follows: briefly, the 
sections were pretreated by rehydrating the tissue sections in PBS-0.1% Triton-
X100 before being exposed to 1N HCl on ice for 10 min and then 2N HCl for 10 
min at room temperature followed by a 40 min incubation in 2N HCl at 37°C.  
Sections were neutralized with 0.1M sodium borate, followed by three 5 min 
washes in PBS-1% Triton-X100.  Endogenous biotin and avidin was blocked 
using the Avidin-Biotin blocking kit (Vector Laboratories) as per the 
manufacturer‟s protocol.  After incubating the section in the blocking reagent 
overnight at 4°C the remainder of the procedure was as per the manufacturer‟s 
protocol.  Finally, sections were counter stained with Hoechst and mounted in 
Prolong (Molecular Probes).  Tissue from the anterior, medial and posterior 
palatal regions of wild-type and Hoxa2 null embryos at E12.5, E13.5 and E14.5 
and 15.5 were used.   
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4.4 TUNEL Assay 
 Cell survival and apoptosis was measured using the DeadEnd 
Fluorometric TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP 
nick-end labelling) System (Promega) as per the manufacturer‟s protocol.  This 
kit exploits the property that, during programmed cell death, chromosomal DNA 
is fragmented.  A recombinant terminal deoxynucleotidyl transferase enzyme is 
used to incorporate fluoroscein-12-dUTP to the free 3'-OH groups of fragmented 
DNA.  The fluoroscein-12-dUTP labeled DNA can then be visualized directly by 
fluorescence microscopy.  Tissue from the anterior, medial and posterior palatal 
regions of wild-type and Hoxa2 null embryos at E12.5, E13.5, and E14.5 were 
examined for apoptotic cell death. Positive controls were performed by staining 
E13.5 hindlimbs which are known to have high levels of apoptosis.  Additionally. 
palatal sections were treated with DNase to fragment DNA and then  stained 
with the TUNEL kit.   
4.5 Whole Palate Organ Cultures 
 Numerous organ culture systems were attempted in order to develop a 
system that could be used to examine if loss of the Hoxa2 gene altered the 
palate shelves ability to fuse with one another.   First, a system was used that 
consisted of removing the tongue and tissue surrounding the palate shelves, 
leaving the snout attached to maintain the correct orientation and curvature of 
the palate shelves which had been reported to maximize the fusion rate (Cuervo 
et al., 2002).  Palates were excised from E14 embryos in Hanks' Balanced Salts 
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or L-15.  The explants were then placed on 13 mm nitrocellulose membrane 
filters, 0.8 µm pore size (Millipore), and the filters placed on Gelfoam surgical 
sponges (Pfizer) in Dublecco's modified eagle medium (DMEM) supplemented 
with 1% penicillin/streptomycin and allowed to grow for 72 h in a 5% CO2 
incubator at 37°C (Chai et al., 1998; Liu et al., 2005).  Cultures were then 
observed under a light microscope to determine if the palate shelves fused.  
Using this technique, only a 60% fusion rate was ever achieved in the wild-type 
animals, which was not effective enough to examine the role of Hoxa2 in fusion.  
A number of variations on this technique were tried, such as supplementing the 
media with HEPES or FBS, allowing a longer period of time for cultures to fuse, 
changing to BGJb media and removing more or less of the surrounding tissue.  
Additionally, Nucleoport Track-Etch membrane filters, 8µm pore size (Whatman) 
were also tried.   
A previously described technique (Nakajima et al., 2007; Shiomi et al., 
2006) with two modifications: the addition of 1M HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) to a final concentration of 20 mM and addition of 
a penicillin-streptomycin antibiotic solution to a final concentration of 0.1% 
(Sigma-Aldrich) proved to be successful. Briefly, the E14.0 palate shelves were 
aseptically excised and arranged in pairs with their medial edges in contact and 
in proper anterior-posterior orientation on Nucleopore Polycarbonate Track-Etch 
filters (Whatman). Two filters were floated in a 35 mm tissue culture dish 
containing 1.4 mL of BGJb medium (Invitrogen), supplemented as detailed  
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72 h, 37
o
C, 5% CO2 
 75 
Figure 8. Schematic Representation of the Organ Culture Technique Used 
to Evaluate Fusion.  
Palate shelves are excised from E14.0 embryos and placed on filters.  The 
filters are floated on BGJb media for 72 h in a 5% CO2 incubator after which 
palates were evaluated for fusion.  
 76 
 above, and incubated in 5% CO2 at 37
oC for 72 h. Following incubation, 
cultures were observed under a light microscope to determine if the epithelial 
seam was lost and palate shelves fused (Fig. 8).  Cultured palatal shelf explants 
were sectioned in a coronal plane and stained with cresyl violet to ensure that 
the midline epithelial seam had degraded.  Fusion rates were compared among 
wild-type, heterozygous and Hoxa2 null mutant embryos to determine if Hoxa2 
played a role in fusion.  
 
4.6 Western Blot Analysis 
Protein was isolated from wild-type and Hoxa2 null mutant embryonic 
palate shelves and pooled together prior to lysis in RIPA buffer (Radio Immuno 
Precipitation Assay Buffer, 150 mM NaCl, 10 mM Tris, 0.1%-SDS, 1% Triton X-
100, 1% Deoxycholate, 5 mM EDTA).  Protein was quantified using the 
Nanovue (General Electric) to ensure that equal loading was achieved.  
Samples were then boiled for 20 min with loading buffer and loaded on a 10% 
polyacrylamide-SDS gel.  After gel separation, the proteins were transferred to 
a PolyScreen PVDF membrane, which was subsequently blocked by overnight 
incubation in 3% skim milk in PBS (SM-PBS) at 4°C.  The membrane was then 
exposed to the primary antibody for either Msx1 (rabbit polyclonal, 
Developmental Studies Hybridoma Bank, 1:500), Fgf8 (mouse monoclonal, 
R&D, 1:500), Ptx1 (goat polyclonal, Santa Cruz, 1:100), Hoxa2 (rabbit 
polyclonal, Hao et al., 1999; Nazarali et al., 2000, 1:1000), Six2 (goat 
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polyclonal, Santa Cruz, 1:200), Bmp4 (goat polyclonal, Santa Cruz, 1:200), 
Barx1 (goat polyclonal, Santa Cruz, 1:200), or Htra3 (rabbit polyclonal, 
(Tocharus et al., 2004), 1:1000) and incubated for 1 h at room temperature.  
This was followed by 3 consecutive washes of 10 min each in PBS with 0.08% 
Tween-20.  After the washes were complete, the membrane was incubated with 
a secondary antibody specific to the species of primary antibody production.  In 
all cases, a species specific IgG horseradish peroxidase conjugate (Bio-Rad) 
was used and diluted to 1:3000 in SM-PBS for 1 h at room temperature.  After 3 
washes of 40 min each in PBS-Tween-20, membrane was exposed with a 
chemiluminescent reagent (DuPont NEN) and signal was detected by exposing 
to X-ray film.  The membrane was then washed overnight at 4°C in PBS before 
being incubated with the anti-β-actin (Sigma) at a dilution of 1:1000, and 
incubated for 1 h at room temperature, followed by 3 washes in PBS with 0.08% 
Tween-20.  After the washes, the membrane was exposed to the anti-mouse 
IgM horseradish peroxidase conjugate (Bio-Rad) in SM-PBS at a dilution of 
1:1500, and then treated as indicated above.  
 Following exposure to film, semi-quantitative densitometry was 
performed using the AlphaImager (Alpha Innotech).  The film was placed on the 
light source and an image was taken, which was then analyzed using the 
AlphaImagers densiometric software to determine an integrated density value 
(IDV) for each of band.  Three separate western blots were performed for each 
of the proteins evaluated. The software allowed for the selection of a 
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representative background area and then to define an area around the bands of 
interest.  Equal size boxes were used in all comparisons. To compare 
expression, relative IDV values were calculated by normalizing to β-actin levels 
from the same sample and then a sample from each gel was set as 1.  Due to 
differences in the IDV values between different blots it was necessary to 
normalize each blot to a band on its own gel to accurately represent any 
changes in protein expression observed.  This was done by normalizing all 3 
western blots to the knockout band from the same age (E12.5, E13.5 or E14.5).  
In order to gain a complete picture, each set of western blots was analyzed 
three times, once normalized to each of the following: E12.5, E13.5 and E14.5 
knock out samples.  Student‟s T-tests were run to compare wild-type and 
knockout expression levels at each of the other two ages.  In all cases where a 
statistically significant change in expression was observed it was significant 
when normalized to either of the two ages.   
4.7 RNA Isolation and Reverse Transcription  
 Total RNA was isolated from excised wild-type and Hoxa2 null embryo 
palate shelves using the RNeasy® Protect Mini Kit (Qiagen) as per the 
manufacturer‟s protocol.  RNA concentration was determined by optical density 
(Nanovue, General Electric).  First strand DNA synthesis was performed using 
the SuperScript® first-strand synthesis system for RT-PCR (Invitrogen), using 
random decamer primers, as per the manufacturer‟s protocol.  Final 
concentration of RNA for all RT reactions was 20 ng/µl. 
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4.8 Quantitative Real Time RT-PCR 
 Gene expression was quantified using the Taqman® primers and labeled 
probe system (Applied Biosystems) and a real time PCR machine (ABI 7300) 
from Applied Biosystems. Wild-type and Hoxa2 mutant embryo palates at 
E12.5, E13.5, E14.5 and E15.5 were tested for each gene, with the exception of 
Hoxa2, where only wild-type tissue was used.  All reactions were performed 
using the Taqman Universal Master Mix (2X), FAM-labeled Taqman Gene 
Expression assays for gene of interest (Msx1, Bmp4, Lef1, Six2, Ptx1, Hoxa2, 
Barx1, Tbx1, Lhx8, Fgf8 or Htra3), VIC-labeled Taqman Endogenous Control β-
Actin, and 10ng of cDNA.  All reactions were run in replicates of 4, and an n=4 
was used for each gene with the exception of Hoxa2 (n=3).  Thermocycling 
parameters were as follows: 2 min at 50oC, 10 min at 95oC, 40 cycles of 15s at 
95oC plus 70s at 60oC. Taqman gene expression assays have all been tested to 
have efficiencies not significantly different from 1 (Applied Biosystems, 2004).  
However,  in order to ensure that all primer sets were working properly and that 
multiplexing the gene specific and β-Actin primers did not result in altered 
amplification efficiencies all primer sets were examined individually and in 
complex with β-Actin.  Standard curve reactions were run using 1 ng, 10 ng and 
100 ng of palate cDNA and amplification efficiency was calculated using the 
equation E=10(-1/slope standard curve) -1 x 100%.  In all cases the efficiency was 
required to be between 90-110% for both the gene specific and β-Actin primers 
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sets before analysis continued. In most cases the appropriate efficiencies were 
possible using 1 μl of the gene specific primer and probe solution and 0.25 μl of 
the β-Actin primer and probe set per reaction.  For the reactions using the 
Hoxa2 and Lhx8 primer and probe sets it was necessary to increase the volume 
of these sets to 2 μl per reaction while leaving the concentration of the β-Actin 
primer and probe set at 0.25 μl.  For the Tbx1 gene specific reactions, it was not 
possible to achieve an acceptable efficiency for both Tbx1 and β-Actin when 
multiplexing.  In this case, the reactions were run in separate wells on the same 
plate.  All comparisons were performed using the relative quantification (RQ) 
software (Applied Biosystems).  
 To ensure that the Hoxa2 primers and probe set was specific, reactions 
were run on cDNA generated from Hoxa2 null embryos and in all cases the Ct 
values generated were well above the acceptable cut off. 
4.9 RT-PCR Analysis 
   RT-PCR was run on cDNA generated from wild-type and Hoxa2 null 
embryos to ensure that Hoxa2 mRNA message could not be detected in the null 
palate shelves.   100 μl PCR reactions contained 1X amplification buffer (VWR), 
2 mM dNTP mix (Sigma), 1μM of each primer (Forward primer : 5‟ ctgg -
atgaaggagaagaaggc and reverse primer : 5‟ cggttctgaaaccacactttc, Invitrogen) 
and 2.5 U of taq (VWR) and 2 μg of cDNA.  Reactions were run on the Biorad 
MyCyclerTM using the temperature cycling conditions 95°C for 4 min followed by 
35 cycles of 95°C for 30 s, 65°C for 3 min and 72°C for 7 min.  PCR samples 
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were then separated on a 1% agarose gel containing ethidium bromide and 
visualized using UV light.   
4.10 Histological analysis  
Time staged embryos were fixed in 4% paraformaldehyde followed by 
immersion in 20% sucrose in PBS.  Frozen embryos in embedding medium 
were sectioned (8 m thick), and tissue sections were collected on gelatin-
coated coverslips.  After sections were allowed to dry for at least two hours they 
were stained with hematoxylin and eosin. 
4.11 Statistical Analysis 
 All statistical analysis and graphs were performed using the GraphPad 
5.0 software package (GraphPad Prism).  Statistical analysis on quantitative 
real time RT-PCR data for Hoxa2 expression was evaluated using one way 
analysis of variance (ANOVA) followed by Bonferroni post-tests to compare 
ages.  Quantitative real time RT-PCR of the expression levels of all putative 
downstream targets was first analyzed in the wild-type embryos to determine 
the normal trend of expression using one way ANOVA and a Bonferroni post-
test.  Comparisons of the expression of putative downstream targets between 
wild-type and Hoxa2 null palates as well as the cell proliferation data were 
analyzed statistically by comparing mean values using two way ANOVA 
followed by Bonferroni post-hoc tests for comparing groups.  Western blot 
densitometry values were compared using Student‟s T-Tests due to the lack of 
variance in the expression of the sample set to equal 1.  A significant p-value of 
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less than or equal to 0.05 was adopted for all comparisons.  
5.0 Results 
5.1 Hoxa2 Expression 
 Hoxa2 expression in the palate has been previously described by our lab 
(Nazarali et al., 2000); however, expression within the palate shelves 
themselves has been disputed by other groups.  To further support our claim 
that Hoxa2 is expressed throughout the developing palate, real time RT-PCR, 
western blot and immunohistochemical reactions were performed.   
Hoxa2 mRNA expression was detected at E12.5, E13.5, E14.5 and 
E15.5 and displays differential expression throughout palatogenesis (p=0.0073, 
F=8.448).  Expression significantly increases between E12.5 and E13.5 
(p<0.05) before Hoxa2 levels decrease at E14.5 and remain low for the 
remainder of palatogenesis (Fig. 9 A).  PCR reactions were also run on RNA 
samples isolated from Hoxa2 null palate shelves to confirm the specificity of the 
signal, and as expected there was no detectable signal in these samples (Fig. 9 
B). 
 Expression of the Hoxa2 protein was detected by western blot analysis at 
E12.5, E13.5, E14.5 and E15.5 (Fig. 10 A).  Densitometry of the western blots 
(n=3) confirmed the trend that protein expression was highest early in 
development, reaching a peak at E13.5 (Fig 10 B).  These results are in 
agreement with the mRNA expression observed after real-time RT-PCR.  
Confirmation that the Hoxa2 antibody is specific was determined by running  
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Figure 9. Hoxa2 mRNA Expression in the Developing Palate 
A) Relative quantitative expression of the Hoxa2 gene throughout murine 
palatogenesis as determined by quantitative real time RT-PCR using Taqman 
primers and probes.  Graph represents mean ± SEM, n=3. * represents a 
significance of p<0.05 between the bars indicated by the brackets.  B) Ethidium 
bromide gel of Hoxa2 mRNA in the wild-type at E13.5 and absence signal was 
observed in Hoxa2 null embryos implying a lack of amplification of Hoxa2 
mRNA. 
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Figure 10. Hoxa2 Protein Expression in the Developing Palate 
A) Western blot analysis of Hoxa2 protein expression levels in the developing 
palate at E12.5, E13.5, E14.5 and E15.5.  Beta-actin levels are used to show 
equal loading of protein between wells.  Hoxa2-/- protein samples are from an 
E13.5 and an E14.5 embryo and confirm the specificity of the antibody to the 
Hoxa2 protein.  B) Densitometry was performed on the western blots (n=3) and 
the expression levels normalized to Beta-actin and relative to E15.5 are shown 
above.  Graph represents mean ± SEM. * denotes p<0.05 and ** denotes 
p<0.01. 
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western blots on protein isolated from the palate shelves of E13.5 and E14.5 
Hoxa2 null embryos.    
 Anterior, medial and posterior sections from E12.5, E13.5, E14.5 and 
E15.5 embryos were analyzed for Hoxa2 protein.  At E12.5 Hoxa2 was 
expressed in both the epithelium and the mesenchyme (Fig. 11 A-C).  Hoxa2 
protein expression increased in both the mesenchyme and epithelium of the 
palate at E13.5 (Fig. 11 E-G).  By E14.5, overall Hoxa2 expression had declined 
throughout the palate with the highest expression observed in the midline 
epithelial seam (Fig. 11 I-K).  At E15.5 the contacted palate shelves had fused 
to gain mesenchymal confluence and low levels of Hoxa2 expression was 
observed throughout the palate (Fig. 11 M-O).   Hoxa2 null palate shelves did 
not show a detectable signal confirming that the antibody is specific for the 
Hoxa2 protein (Fig. 11 D,H,L,P). These data also correspond with the levels 
observed by real time RT-PCR and western blot analyses.  
5.2 Histology 
 Wild-type and Hoxa2 null embryos were sectioned in a coronal plane to 
examine if there was an alteration in the shape, size or orientation of the null 
palates compared to wild-type controls.  Anterior, medial and posterior regions 
were examined between E12.5 and E15.5.  Initially, there did not appear to be 
any gross differences in the appearance of the palate shelves in the Hoxa2 null 
animals (Fig. 12 A-D).  At E14.5 in wild-type animals, the palate shelves have 
flipped to be oriented horizontally above the tongue and by E15.5 they have 
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Figure 11. Immunohistochemical Staining for Hoxa2 Protein in the Mouse 
Palate. 
Anterior, medial and posterior palate sections are in the same orientation and 
from the same embryo.  Green nuclear staining represents the expression of 
the Hoxa2 protein at E12.5 (A-C), E13.5 (E-G), E14.5 (I-K) and E15.5 (M-O).  
Sections of the Hoxa2-/- palates (D,H,L,P) are from the anterior palate regions at 
the ages denoted on the left.  These sections clearly show a lack of staining in 
the Hoxa2-/- palates confirming the specificity of the antibody. Arrow is pointing 
the epithelium. M, mesenchyme, T, tongue.  
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Figure 12. Histological Analysis of the Palate Shelves 
Coronal sections of wild-type and Hoxa2 null palate shelves were stained with 
Hemotoxylin and Eosin to compare the gross morphology of the palate shelves.  
Representative medial sections are shown.  Palate shelves fail to elevate above 
the tongue in Hoxa2 null embryos. P=palate shelf, T=Tongue. 
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undergone fusion to form a confluent palate (Fig. 12.E,G).  Loss of the Hoxa2 
gene appears to result in problems at this stage as palate shelves remain 
vertically oriented in most animals even at E15.5 (Fig. 12 F,H).      
5.3 Cell Proliferation Assay 
 To determine whether a loss of Hoxa2 expression in the palate resulted 
in alterations in the growth of the palate primordia, cell proliferation rates were 
compared within the anterior, medial, and posterior regions of the palate in wild-
type and Hoxa2 null palates at stages E12.5 through E15.5 (n=4) (Fig. 13 and 
14).  Two-way ANOVA analysis revealed that in all three regions of the palate, 
the interaction between the genotype and developmental stage was significant 
(p<0.001).  An overall increase in proliferation rates in the Hoxa2 null palate 
shelves was observed.  In the anterior of the palate, a significant increase in 
proliferation rates were observed at E12.5, E14.5 and E15.5 (p<0.001) (Fig. 14 
A).  A similar trend was also observed in the medial (Fig. 14 B) and posterior 
(Fig. 14 C) palate with a significant increase at E12.5 and E14.5 (p<0.001) in 
both regions. 
5.4 Apoptosis analysis 
To examine whether the survival of cells in the developing palate is 
changed in the absence of Hoxa2, the level of apoptosis was compared 
between wild-type and Hoxa2 null palates at E12.5, E13.5 and E14.5 using the 
DeadEnd Fluorometric TUNEL (terminal deoxynucleotidyl transferase-mediated 
dUTP nick-end labelling) System (Promega).  The anterior, medial                     
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Figure 13. Immunohistochemical Analysis of BrdU Uptake to Compare 
Proliferation Rates between Wild-type and Hoxa2 null palates 
Representative medial sections from E12.5 embryos of wild-type (Hoxa2 +/+) 
and Hoxa2 null (Hoxa2 -/-) palate shelves stained with a BrdU specific antibody 
(green), and Hoechst (blue).  A clear increase in the number of BrdU positive 
cells can be seen in the Hoxa2 null sample indicative of an increase in 
proliferation in the absence of the Hoxa2 gene. P=palatal shelf, T=tongue. 
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Figure 14. Increased Cell Proliferation Rates within Hoxa2 null Palates 
Cell proliferation rates within the developing palate shown as mean percentage 
of cells that are BrdU positive per µm2 ± SEM.  Sections from the anterior (A), 
medial (B) and posterior (C) regions of the palate were analyzed at E12.5, 
E13.5, E14.5 and E15.5 of wild-type and Hoxa2 null palates (n=4). 
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and posterior was examined at each age (n=3).  No difference was observed in 
the number of apoptotic cells at any developmental stage between the wild-type 
and Hoxa2 null palates (Fig. 15). 
 To confirm these findings, sections from the anterior, medial and 
posterior of E12.5, E13.5 and E14.5 of wild-type and Hoxa2 null palates were 
stained with an antibody specific for the activated caspase 3 protein,  another 
hallmark of apoptosis (Fig. 16).  Once again no difference was observed in the 
number of apoptotic cells in the palates of Hoxa2 null embryos at any stage.   
5.5 Organ Cultures 
 To determine whether Hoxa2 null palates are capable of fusing together, 
an organ culture technique was employed.  Palate shelves were placed in 
contact with one another and allowed 72 h to fuse. Fusion rates were not 
significantly different between wild-type, heterozygous and Hoxa2 null palates 
(Fig. 17 B).  Sections of the cultured palates were stained with cresyl violet to 
confirm mesenchymal confluence had occurred (Fig. 17 A).  Hoxa2 null palates 
were equally capable of fusing as their wild-type controls.  
5.6 Msx1 Expression 
Msx1 expression within the developing palate has been well 
characterized (Zhang et al., 2002).  Quantitative real time RT-PCR showed 
expression at all stages of development in both the wild-type and Hoxa2 null 
palatal shelves (Fig. 18 A).  Two-way ANOVA showed that there was a 
significant interaction between genotype and embryonic age (p=0.0012,  
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Figure 15. TUNEL analysis shows Apoptosis was not Altered in Hoxa2 null 
Palates 
Wild-type and Hoxa2 null palates at E12.5 (A,B), E13.5 (C,D) and E14.5 (E,F) 
(n=3) were analyzed by TUNEL to compare the level of apoptosis. Green 
stained cells were positive for fragmented DNA and therefore determined to be 
apoptotic.   Loss of Hoxa2 expression did not lead to a detectable change in the 
level of apoptosis.  Representative medial sections are shown.  Control section 
is from an E13.5 hindlimb.  P=palatal shelf, T=tongue. 
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Figure 16. Analysis of Activated Caspase 3 shows Apoptosis is not 
Altered in Hoxa2 null Palates 
Wild-type and Hoxa2 null palates at E12.5 (A.B), E13.5 (C,D) and E14.5 (E,F) 
(n=3) were analyzed by immunohistochemical analysis for activated caspase 3  
to compare the level of apoptosis.  Green staining is specific for activated 
caspase 3, while nuclei are stained in blue with Hoechst.  Loss of Hoxa2 
expression did not lead to a detectable change in the level of apoptosis.  
Representative medial sections are shown.  Control section is from an E13.5 
hindlimb.  P=palatal shelf, T=tongue. 
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Genotype of the 
Embryo 
Number of 
Palates Fused 
Total Number of 
Palates Cultured 
Percentage of 
Fused Palates 
Wild-type 12 14 87.5 % 
Heterozygous 14 15 93.3 % 
Hoxa2 null 6 7 87.5% 
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Figure 17. Absence of the Hoxa2 gene does not Alter the Ability of Palate 
Shelves to Fuse.  
Palate shelves were dissected from wild-type (WT), heterozygous and Hoxa2 
null (KO) embryos at E14.0 and placed in contact with one another  After 72 h in 
culture the palates were assessed for fusion before being fixed, sectioned and 
stained with cresyl violet to check for degradation of the epithelial seam.  
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Figure 18. Enhanced Msx1 Expression in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Msx1 throughout murine palatogenesis in 
Hoxa2+/+ and Hoxa2-/- palates.  (A) mRNA expression was determined by 
quantitative real time RT-PCR using Taqman primers and probes.  Bars 
represent mean ± SEM, n=4. (B) Msx1 protein expression was determined by 
western blot analysis of palatal protein.  Beta-actin is used to show equal 
loading of protein between samples. (C) Densitometry of the western blots was 
performed to determine a trend in expression levels.  Bars represent mean ± 
SEM, n=3. *  p<0.05, ** p<0.01. 
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F=7.331).  Analysis of the expression of Msx1 in the wild-type palate showed 
differential expression throughout palatogenesis, significantly increasing 
between E12.5 and E13.5 (p<0.01) in wild-type palate shelves and remaining 
elevated at E14.5 before decreasing at E15.5 (p<0.001).  Analysis of 
expression levels in the Hoxa2 null animals revealed that expression was not 
significantly different between E12.5, E13.5 and E14.5 but did decrease at 
E15.5 (p<0.05).  Hoxa2 null embryos display a significant increase in mRNA 
expression levels at E12.5 (p<0.01), but return to normal wild-type levels 
throughout the remainder of palatogenesis (Fig. 18 A). 
 Western blot analysis was performed to determine protein expression of 
Msx1.  Wild-type and Hoxa2 null palate shelves were analyzed at E12.5, E13.5, 
and E14.5 (Fig. 18 B).  Msx1 protein was detected in both wild-type and null 
palate shelves.  Densitometry of the western blots (n=3) confirmed that Msx1 
protein is increased in the Hoxa2 null palates at E12.5 (p<0.05).   By E13.5, the 
expression of the Msx1 protein does not appear to be different between wild-
type and Hoxa2 null samples (Fig. 18 C).  The protein expression trend 
matches the mRNA expression profile determined by real time RT-PCR. 
5.7 Bmp4 Expression 
 Bmp4 expression was examined as it is known to be expressed within 
the palate and is a downstream target of Msx1 (Zhang, et al., 2002).  Our 
results confirm that Bmp4 mRNA is present at E12.5, E13.5, E14.5 and E15.5 in 
the wild-type palate, with no statistical differences in expression levels 
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throughout development (Fig. 19 A). Two-way ANOVA revealed a significant 
interaction between genotype and embryonic age (p=0.0069, F=7.331).    
Absence of Hoxa2 from the palate shelves resulted in a significant increase in 
the expression level of Bmp4 only at E12.5 (p< 0.001)(Fig. 19A).  This increase 
in expression corresponds well with the increase in Msx1 expression at the 
same stage.  Bmp4 protein expression was also examined using western blot 
analysis.  Protein expression increased substantially at E13.5 representing a 
slight delay following the increase in mRNA at E12.5 (Fig. 19 B).  Densitometry 
revealed that the Bmp4 protein is increased within the Hoxa2 null palate 
shelves at E13.5 (p<0.05) but appears to return to wild-type levels by E14.5 
(Fig. 19 C).   
5.8 Barx1 Expression 
 Hoxa2 is expressed throughout the developing palate and therefore, 
examining the expression of a posterior specific protein will help determine if 
there is a role for Hoxa2 in this region of the palate.  Barx1 expression has 
previously been described in the developing palate (Welsh et al., 2007).  
Expression was detected at E12.5, E13.5, E14.5 and E15.5 within the palate 
shelves throughout palatogenesis.  Two-way ANOVA did not reveal an 
interaction between genotype and age (p=0.5731, F=0.6803).  Expression in 
Hoxa2 null palate shelves was significantly increased compared to wild-type 
controls at E13.5.  No detectable difference was determined at any other 
developmental stage (Fig. 20 A).  Alteration of Barx1 at E13.5 suggests that 
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Figure 19. Enhanced Bmp4 Expression in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Bmp4 throughout murine palatogenesis in 
Hoxa2+/+ and Hoxa2-/- palates.  (A) mRNA expression was determined by 
quantitative real time RT-PCR using Taqman primers and probes.  Bars 
represent mean ± SEM, n=4. (B) Bmp4 protein expression was determined by 
western blot analysis of palatal protein.  Beta-actin is used to show equal 
loading of protein between samples. (C) Densitometry of the western blots was 
performed to determine a trend in expression levels.  Bars represent mean ± 
SEM, n=3. *  p<0.05. 
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Figure 20. Enhanced Barx1 Expression in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Barx1 throughout murine palatogenesis in 
Hoxa2+/+ and Hoxa2-/- palates.  (A) mRNA expression was determined by 
quantitative real time RT-PCR using Taqman primers and probes.  Bars 
represent mean ± SEM, n=4. (B) Barx1 protein expression was determined by 
western blot analysis of palatal protein.  Beta-actin is used to show equal 
loading of protein between samples. (C) Densitometry of the western blots was 
performed to determine a trend in expression levels.  Bars represent mean ± 
SEM, n=3. *  p<0.05. 
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there is a role for Hoxa2 in regulating posterior palate development.   
To confirm the increase in Barx1 the levels of the protein were also 
examined by western blot analysis of wild-type and Hoxa2 null palates at E12.5, 
E13.5 and E14.5 (n=3)(Fig. 20 B).  In agreement with the changes in mRNA 
levels, an increase in the levels of Barx1 protein was observed at E13.5 
(p<0.05) (Fig 20 C). 
5.9 Ptx1 Expression 
 Ptx1 expression has previously been detected by in situ hybridization 
histochemistry in the first branchial arch and its derivatives, including the palate 
at E15 (Bobola, et al., 2003; Lanctot, et al., 1997).  Using quantitative real time 
RT-PCR Ptx1 expression was detected in both wild-type and Hoxa2 null palatal 
shelves at E12.5, E13.5, E14.5 and E15.5 (Fig. 21 A). Two-way ANOVA did not 
reveal a significant effect of interaction (p=0.1034, F=2.426).  Expression was 
not significantly altered throughout development.  A significant increase in Ptx1 
mRNA expression was seen in Hoxa2 null palatal shelves at E13.5 compared to 
wild-type (p<0.05).  
 Protein expression of Ptx1 was also detectable in the palate by western 
blot analysis.  A trend of increased expression of Ptx1 protein in the Hoxa2 null 
palate shelves compared to wild-type palates was seen at E13.5 and E14.5 
(Fig.  21 B), however densitometry revealed a significant increase only at E13.5 
was significant (p<0.05) (Fig. 21 C).  These data correspond with the observed  
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Figure 21. Enhanced Ptx1 Expression in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Ptx1 throughout murine palatogenesis in 
Hoxa2+/+ and Hoxa2-/- palates.  (A) mRNA expression was determined by 
quantitative real time RT-PCR using Taqman primers and probes.  Bars 
represent mean ± SEM, n=4. (B) Ptx1 protein expression was determined by 
western blot analysis of palatal protein.  Beta-actin is used to show equal 
loading of protein between samples. (C) Densitometry of the western blots was 
performed to determine a trend in expression levels.  Bars represent mean ± 
SEM, n=3. * p<0.05, **p<0.01.  
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increase of mRNA at E13.5. 
5.10 Fgf8 Expression 
 It is predicted that regulation of Ptx1 expression by Hoxa2 involves Fgf8  
and its signalling pathway (Bobola et al., 2003).   Quantitative real time RT-PCR 
was employed to determine whether Fgf8 was expressed in the palate and if the 
loss of the Hoxa2 gene altered its expression.  Fgf8 mRNA expression was 
detected in palatal shelves from E12.5, E13.5, E14.5 and E15.5 embryos, with 
the highest level observed at E12.5.  After this point, expression decreased 
dramatically and remained low for the remainder of palatogenesis.  Loss of the 
Hoxa2 gene did not appear to alter palatal Fgf8 mRNA expression (Fig. 22 A).  
 Western blot analysis was used to confirm the presence of Fgf8 protein 
in the palate, as well as to determine if differences existed in expression 
between Hoxa2 null and wild-type palate shelves.  Fgf8 protein was detected at 
E12.5, E13.5 and E14.5 with no observable differences in the null palate 
samples (Fig. 22 B and C).  Interestingly, Fgf8 protein expression was relatively 
consistent throughout development, which does not correspond with the 
significantly higher levels of mRNA observed at E12.5 than the other ages.  This 
could be the result of a disconnect between mRNA levels and protein levels.  
Alternatively the Fgf8 antibosy may be detecting other Fgf family members.   It 
does appear that there is not an alteration of expression in the absence of 
Hoxa2. 
Fgf8 protein expression was also examined at E12.5, E13.5, E14.5 and 
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Figure 22. Fgf8 Expression is not Altered in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Fgf8 throughout murine palatogenesis in 
Hoxa2+/+ and Hoxa2-/- palates.  (A) mRNA expression was determined by 
quantitative real time RT-PCR using Taqman primers and probes.  Bars 
represent mean ± SEM, n=4. (B) Fgf8 protein expression was determined by 
western blot analysis of palatal protein.  Beta-actin is used to show equal 
loading of protein between samples. (C) Densitometry of the western blots was 
performed to determine a trend in expression levels.  Bars represent mean ± 
SEM, n=3.  
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E15.5 in the anterior, medial and posterior regions following 
immunohistochemical analyses.  Data suggests that Fgf8 protein is present 
throughout the developing palate in both the epithelium and mesenchyme.  The 
signal from immunohistochemical analyses was difficult to quantify as Fgf8 is a 
diffusible protein, however, significant changes were not noticeable between the 
wild-type and Hoxa2 null palates (Fig. 23).   
5.11 Lhx8 Expression 
 Lhx8 is another known downstream target of Fgf8 signalling (Inoue et al., 
2006).  Lhx8 has previously been shown to be expressed in the palate, and 
absence of Lhx8 expression has been shown to lead to cleft palate mice (Zhao 
et al., 1999).  To determine whether Lhx8 mRNA expression in the developing 
palate was altered in the absence of Hoxa2, quantitative real time RT-PCR was 
used.  Expression of Lhx8 was detected at all four embryonic stages and Two-
way ANOVA revealed differential expression throughout palatogenesis 
(p=0.0001, F=26.38) with the highest expression observed early in 
development, decreasing as palatogenesis proceeds.  Loss of the Hoxa2 gene 
did not significantly alter the expression of Lhx8 at any stage of development 
(p=0.8006, F=0.06525) (Fig. 24).  These data show that although the role of 
Hoxa2 on Ptx1 expression may occur via Fgf8 not all downstream targets of 
Fgf8 are altered.   
5.12 Six2 Expression 
 Six2 is known to be directly repressed by Hoxa2 in the branchial arches 
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Figure 23. Fgf8 Protein is Expressed Within the Developing Palate. 
Immunohistochemical analysis of Fgf8 expression within the developing palate 
at E12.5 (A,B), E13.5 (C,D), E14.5 (E,F), E15.5 (G,H) of both Hoxa2+/+ and 
Hoxa2-/- embryos.  Representative medial sections are shown above.  
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Figure 24. Lhx8 mRNA Expression is not Altered in the Absence of Hoxa2. 
Relative quantitative expression of Lhx8 throughout murine palatogenesis in 
Hoxa2+/+ (wild-type) and Hoxa2-/- (knock-out) embryos. mRNA levels were 
determined by quantitative real time RT-PCR using Taqman primers and 
probes.  Bars represent mean ± SEM, n=4. 
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(Kutejova et al., 2005; Kutejova et al., 2008).  Expression within the developing 
palate has not previously been reported.   For the first time, the presence of 
Six2 mRNA was shown in palate shelves at E12.5, E13.5, E14.5 and E15.5.  A 
statistical interaction between genotype and embryonic age was detected for 
the expression of Six2 mRNA in the palate (p=0.0103, F=4.654).  In wild-type 
embryos expression was differentially expressed throughout the development of 
the palate (p= 0.0079, F=6.370) with levels declining between E12.5 and E15.5 
(Fig. 25 A).  Hoxa2 null palate shelves show significantly increased expression 
of Six2 mRNA during the early stages of palate development [E12.5 (p<0.05), 
E13.5 (p<0.01)] and at E15.5 (p<0.05) (Fig. 25 A).  
 Six2 protein expression was also observed in the developing palate 
using western blot analysis (Fig. 25 B).   Densitometry of the western blots 
(n=3) revealed that the Six2 protein is more abundant in the palate shelves of 
Hoxa2 null embryos at E12.5 (p<0.01), E13.5 (p<0.05) and E14.5 (p<0.05) (Fig. 
25 C).  Immunohistochemical analyses of wild-type and Hoxa2 null palates were 
examined at all four stages of development in the anterior, medial and posterior 
(Fig. 26).  Protein expression was detected throughout the palate at all 
developmental stages with an increased signal detected in the Hoxa2 null 
palates.  The protein data therefore is in agreement with the quantitative real 
time results, where an apparent increase in Six2 expression levels is observed 
in the Hoxa2 null palate shelves.    
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Figure 25. Enhanced Six2 Expression in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Six2 throughout murine palatogenesis in 
Hoxa2+/+ and Hoxa2-/- palates.  (A) mRNA expression was determined by 
quantitative real time RT-PCR using Taqman primers and probes.  Bars 
represent mean ± SEM, n=4. (B) Six2 protein expression was determined by 
western blot analysis of palatal protein.  Beta-actin is used to show equal 
loading of protein between samples. (C) Densitometry of the western blots was 
performed to determine a trend in expression levels.  Bars represent mean ± 
SEM, n=3. * p<0.05, **p<0.01.  
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Figure 26. Immunohistochemical Analysis of Six2 Expression  
Immunohistochemical staining for Six2( red) on coronal sections from mouse 
palatal shelves at E12 (A,B), E13 (C,D), E14 (E,F) and E15 (G,H).  Hoxa2-/- 
palates show an increase in Six2 staining.  Representative medial sections are 
shown above.  P=palatal shelf, T=tongue. 
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5.13 Tbx1 Expression 
 Expression of the Tbx1 gene is known to be crucial for normal 
palatogenesis (Jerome and Papaioannou, 2001). The expression of Tbx1 
mRNA was examined in the palate of wild-type and Hoxa2 null embryos.  A 
statistical interaction on the expression of Tbx1 was shown between genotype 
and embryonic age (p=0.0012, F=8.654).  Tbx1 mRNA was detected at all four 
developmental stages, showing differential expression throughout development 
(p=0.0001, F=22.18), with levels increasing as palate development proceeds.  
Unlike other downstream targets of Hoxa2 in the palate, which are repressed 
only at the early stages of palate development, Tbx1 expression remains 
unchanged in early development and is only significantly increased at E15.5 
(p<0.001) (Fig. 27).  These data demonstrate that Hoxa2 also plays a role at 
later stages of development although at present it is not clear what this role is. 
5.14 Lef1 Expression  
 Lef1 expression was detected in the developing palate shelves of wild-
type mice at E12.5, E13.5, E14.5 and E15.5.  A statistical interaction between 
genotype and embryonic age on the expression level of Lef1 mRNA was 
detected by two way ANOVA (p<0.0001, F=26.38).  Expression was variable 
throughout palatogenesis in the wild-type embryo between E12.5 and E13.5 
(p<0.01), followed by a significant decrease in expression by E15.5 (p<0.01).  
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Figure 27. Enhanced Tbx1 Expression in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Tbx1 throughout murine palatogenesis in 
Hoxa2+/+ (wild-type) and Hoxa2-/- (knock-out) embryos. mRNA levels were 
determined by quantitative real time RT-PCR using Taqman primers and 
probes.  Bars represent mean ± SEM, n=4. * p<0.05. 
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 Hoxa2 null embryos show a significant increase in the expression levels of Lef1 
at E12.5 (p<0.001).  Expression decreased rapidly and returns to wild-type 
levels by E13.5 with little change at E14.5 and E15.5 (Fig. 28).  
5.15 Htra3 Expression 
 Quantitative real time RT-PCR analysis revealed novel Htra3 expression 
in the palatal shelves at E12.5, E13.5, E14.5 and E15.5.  Expression levels in 
wild-type embryos increased as palate development proceeds (p=0.007, 
F=8..099), with low levels observed at E12.5 and a peak in expression by E15.5 
(p<0.05).  Hoxa2 null palatal shelves also displayed Htra3 expression at all of 
the above stages.  The expression profile in these mutants was not significantly 
different from the wild-type (p=0.6102) (Fig. 29 A).  
 Htra3 protein expression was detected in the palate using western blot 
analysis at E12.5, E13.5 and E14.5.  Protein expression appeared to be 
relatively constant throughout palate development.  No change was observed in 
expression between Hoxa2 null palate shelf samples and wild-type controls 
(Fig. 29 B and C).  
Htra3 expression was also detected using immunohistochemistry, 
showing increasing expression within the palate as development proceeds.  
Expression appears to be strongest in the medial region of the palate (Fig. 30).  
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Figure 28. Enhanced Lef1 Expression in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Lef1 throughout murine palatogenesis in 
Hoxa2+/+ (wild-type) and Hoxa2-/- (knock-out) embryos. mRNA levels were 
determined by quantitative real time RT-PCR using Taqman primers and 
probes.  Bars represent mean ± SEM, n=4. ** p<0.01. 
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Figure 29. Expression of Htra3 is not Altered in Hoxa2 null Palate Shelves. 
Relative quantitative expression of Htra3 throughout murine palatogenesis in 
Hoxa2+/+ and Hoxa2-/- palates.  (A) mRNA expression was determined by 
quantitative real time RT-PCR using Taqman primers and probes.  Bars 
represent mean ± SEM, n=4. (B) Htra3 protein expression was determined by 
western blot analysis of palatal protein.  Beta-actin is used to show equal 
loading of protein between samples. (C) Densitometry of the western blots was 
performed to determine a trend in expression levels.  Bars represent mean ± 
SEM, n=3.   
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Figure 30. Immunohistochemical Analysis of Htra3 Protein Expression in 
the Palate 
Immunohistochemical analysis of the Htra3 (green) protein expression in the 
anterior, medial and posterior regions of the palate at E13.5 (A,B,C), E14.5 
(D,E,F) and E15.5 (G,H,I).  Htra3 expression appears most intense in the 
medial regions of the palate with increasing expression as development 
proceeds.  
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6. Discussion 
6.1 Hoxa2 is Expressed in the Secondary Palate 
 The tissue that forms the secondary palate develops as outgrowths of 
the maxillary prominences, which are known to be derivatives of the first 
branchial arch.  The CNCC that migrate into the first branchial arch have been 
shown to originate from r1 and r2.  The CNCC from the first two rhombomeres 
have been shown to be devoid of Hox gene expression at this stage.  In 
contrast, the cells that migrate to form the second branchial arch originate from 
r4 and are known to express Hoxa2.  Before the onset of CNCC migration from 
the rhombomeres, the expression domain of Hoxa2 expands to the r1/2 
boundary (Prince and Lumsden, 1994; Rijli et al., 1993).  Hence, the cells that 
are migrating in the first branchial arch which will eventually populate the 
secondary palate are null of Hox gene expression during their migration, but 
were previously capable of Hoxa2 expression.   
The presence of a cleft palate in approximately 80% of Hoxa2 null mice 
has been postulated to be a secondary defect to abnormal tongue development 
(Barrow and Capecchi, 1999).  This theory is generally accepted due to the 
absence of Hoxa2 expression in the first branchial arch, from which the 
secondary palate is derived.  The muscles of the tongue attach to the hyoid 
bone, a derivative of the second branchial arch, which does normally express 
Hoxa2.  It was therefore previously suggested, that the secondary palate is also 
void of Hoxa2 expression and therefore a loss of expression in the knockout 
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could not lead to alterations in the development of the palate proper.  Recent 
data however suggests Hoxa2 is expressed within the developing palate 
(Nazarali et al., 2000).  Furthermore, whole organ culture data suggest an 
increased incidence of cleft palate in Hoxa2 null palates grown in the absence 
of the tongue (Zhang, 2003).  Together, these data suggest a more direct role 
for Hoxa2 in regulating palatogenesis. 
 To further support a direct role for Hoxa2 in the palate, a more thorough 
and detailed analysis of Hoxa2 expression within the palate was required.  
Expression of Hoxa2 was analyzed at both the mRNA and protein levels.  
Hoxa2 mRNA was detected in the palate at E12.5, E13.5, E14.5 and E15.5 
using quantitative real time RT-PCR (Fig.9 A).  Levels of the Hoxa2 mRNA were 
significantly higher at E12.5 and E13.5 than later in development with peak 
expression occurring at E13.5.  These data would suggest that there may be an 
important role in the early growth of the palate shelves.  Expression is detected 
until E15.5 and therefore a role in fusion is possible as well.   In addition, Hoxa2 
protein expression was also detected in the secondary palate using both 
western blot and immunohistochemical analysis (Fig. 10).  The protein levels 
were also highest in the palate at the early stages of development (E12.5 and 
E13.5) which agreed with the real-time RT-PCR results and confirmed the 
previously reported expression profile of Hoxa2 within the palate (Nazarali et al., 
2000).   
Immunohistochemical analysis allowed for the determination of the 
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location of expression within the palate in addition to confirming the expression 
levels seen by real-time RT-PCR and western blot analysis.  Low levels of 
Hoxa2 protein was observed in both the mesenchyme and the epithelium of the 
palate at E12.5 after which the levels in both increase significantly.  At E14.5 
Hoxa2 is detected most intensely in the midline epithelial seam.  By E15.5 there 
is only minimal Hoxa2 expression throughout the palate (Fig. 11).  Schematic 
representation of the expression profile of the Hoxa2 protein can be seen in 
figure 31.  In all cases the highest expression was observed during the early 
stages of palate development with a significant peak in expression at E13.5.  
Expression predominantly during the early stages of palatogenesis suggests 
that the role of Hoxa2 is likely to be in the growth and development of the palate 
shelves. The expression profile described above closely matches the 
expression profile that had been previously reported (Nazarali et al., 2000).   
 These data confirm that despite an absence of Hoxa2 expression within 
the migrating first branchial arch, it is expressed within its derivative the 
secondary palate.  This implies that an absence of expression in the migrating 
cells that populate the branchial arches does not ensure that expression of 
genes is not turned on later in development once the first arch migrating neural 
crest cells differentiate into its later derived structures such as the secondary 
palate. Expression of Hoxa2 within the palate during its crucial stages of 
development suggests that there is likely to be a direct role for Hoxa2 in 
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Figure 31.  Schematic Representation of Hoxa2 Protein Expression 
Green dots indicate areas that are expressing the Hoxa2 protein.  Expression is 
seen in both the epithelium and mesenchyme throughout the palate at all ages.  
Highest levels of expression are seen at E13.5 and along the epithelial seam at 
E14.5. 
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regulating the development of the palate, and that the high incidence of cleft 
palate seen in Hoxa2 null embryos may in fact be due to a primary defect in 
palate development. 
6.2 Altered Palate Growth in Hoxa2 null Embryos 
 The expression of Hoxa2 within the developing palate strongly suggested 
a direct role for the gene in regulating proper palate development.  In order to 
confirm this, various cell processes and stages of palate development were 
examined and comparisons made between wild-type and Hoxa2 null embryos.  
The major processes involved in palate development include proper timing of 
the growth, elevation and fusion of the palate shelves.  Each of these stages 
was examined in the Hoxa2 null palates and compared to wild-type controls.  
 The growth of the palate shelves occurs throughout palatogenesis 
beginning at E11.5 when the shelves bud from the maxillary prominences and 
continues as they grow vertically, and after they reorient to their final horizontal 
position.  It is essential that the growth of the palates be tightly regulated in 
order to ensure that they are large enough to contact one another once they are 
oriented above the tongue, but that they remain small enough that they are 
capable of flipping up when the tongue flattens.  If the timing of the growth and 
development of the palate is not coordinated with that of the tongue, then the 
tongue can act as a physical barrier and lead to a cleft palate.    
To determine if Hoxa2 has an effect on the growth of the palate shelves, 
wild-type and Hoxa2 null palates were analyzed for both proliferation and 
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apoptosis rates.  TUNEL analysis was used to specifically label fragmented 
chromosomal DNA which is a hallmark of apoptosis.  Results of this analysis 
revealed that apoptosis was not altered in Hoxa2 null palate shelves at E12.5, 
E13.5 or E14.5 compared to wild-type animals (Fig. 15).  These findings were 
confirmed by staining wild-type and Hoxa2 null palates with an antibody specific 
for the activated form of the caspase 3 enzyme (Fig. 16).  Using both 
techniques demonstrated that only a low level of programmed cell death was 
observed within the palate at any stage of its development and a difference 
between the rates of apoptosis was not evident at any point in development.  
 Alternatively, cell proliferation rates do vary in Hoxa2 null palates (Fig. 
14).  BrdU incorporation was used to label dividing cells, followed by 
immunohistochemical analysis.  Proliferation rates were then calculated by the 
percentage of cells that were BrdU positive cells per μm2.  Counts were only 
done in the palatal mesenchyme as accurate counts of the total number of cells 
in the epithelium were not possible due to the dense cell population.  The 
anterior, medial and posterior regions of the palates were examined at E12.5, 
E13.5, E14.5 and E15.5.  Overall the general trend suggested an increase in 
the rate of proliferation in the Hoxa2 null palate shelves.  Initially, it would seem 
that an increase in proliferation is unlikely to lead to a cleft palate.  This 
phenomena has, however, been previously reported in mice lacking the Fgf 
antagonist Spry2 (Welsh et al., 2007).  Interestingly, the cleft palate penetrance 
in these animals is 83% which is very similar to that seen in Hoxa2 null mice 
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(81%).  
In many cases, alterations in proliferation are only observed in either the 
anterior or posterior regions of the palate.  Hoxa2 null palates display an overall 
increase in cell proliferation throughout the developing palate.  The Hoxa2 
protein is expressed throughout the palate as well, so this result is not 
surprising. Distinct pathways are known to regulate growth of the anterior and 
posterior palate, and therefore these results suggest that Hoxa2 is likely to be 
involved in the regulation of a variety of pathways that control proliferation in the 
palate.  
6.3 Palatal Shelves Fail to Elevate in Hoxa2 null Embryos 
 To determine if an increase in palate growth due to increased cell 
proliferation led to problems with proper elevation of the palate shelves, 
histology was performed on wild-type and Hoxa2 palate sections.  The major 
difference in development appears to occur at E14.5.  In the wild-type embryos 
the palate shelves have elevated and are positioned horizontally above the 
tongue.  Hoxa2 null palate shelves fail to elevate at E14.5 and even by E15.5 
when wild-type palates have fused the null palate shelves remain oriented in a 
vertical direction (Fig. 12).  This observation, along with the data from the cell 
proliferation studies, provides a clearer understanding of the defects in palate 
development in Hoxa2 null animals.  These combined data suggest that one of 
the possible mechanisms of cleft in null embryos is the increase in proliferation 
in the palate leads to a loss of the coordinated development normally occurring 
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between the palate and other craniofacial structures such as the tongue and 
mandible. 
 Mechanisms of palate shelf elevation were not directly investigated, as 
they are poorly described in the literature.  It is largely accepted that palate shelf 
elevation is the result of both intrinsic forces within the palate shelves, and 
proper coordination of growth between the palate shelves and other craniofacial 
structures.  The extracellular matrix has been demonstrated to progressively 
accumulate hyaluronan, which is capable of retaining a large quantity of water 
and is predicted to provide the changes in rigidity required for the rapid 
elevation of the palate shelves (Brinkley and Morris-Wiman, 1984; Brinkley and 
Morris-Wiman, 1987; Ferguson, 1978; Larsson et al., 1959; Pratt et al., 1973; 
Singh et al., 1994; Singh et al., 1997).  Changes in rigidity have also been 
attributed to variations in blood flow to the palate shelves (Amin et al., 1994), 
and increased cell proliferation and change in morphology in specific regions of 
the mesenchyme elevation (Babiarz et al., 1979; Brinkley, 1980; Brinkley and 
Bookstein, 1986; Bulleit and Zimmerman, 1985; Greene and Pratt, 1976; 
Greene and Pratt, 1976; Innes, 1978).  
 The only target that has been identified to play a role in elevation is the 
neurotransmitter γ-aminobutyric acid (GABA).  Agonists of GABA have been 
shown to result in cleft palate through inhibition of palate shelf elevation, 
whereas antagonists have been shown to stimulate elevation (Miller and 
Becker, 1975; Wee and Zimmerman, 1983).  Glutamic acid decarboxylase 67 
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(Gad 67) is involved in the synthesis of GABA, and both have been shown to be 
expressed within the developing palate (Asada et al., 1997; Hagiwara et al., 
2003; Wee et al., 1986).  It is possible that the loss of the Hoxa2 gene does 
lead to defects in the intrinsic mechanisms involved in palate shelf elevation, but 
this will require further studies.  
6.4 Physical Barrier of the Tongue Appears to be Secondary to Altered 
Palate Growth 
Previous research in our lab investigated the ability of the palates to fuse 
in the absence of the tongue.  Organ cultures were performed where the lower 
mandible was removed including the tongue and the palate was cultured and 
then examined for fusion.  These experiments showed that in the absence of 
the Hoxa2 gene the ability of the palate shelves to fuse was significantly 
decreased (Wang, 2006; Zhang, 2003).  This, in combination with the new 
increased proliferation data, shows that the loss of the Hoxa2 gene does in fact 
lead to problems in the development of the palate proper which ultimately leads 
to the formation of a cleft palate. Although the fusion rate in these Hoxa2 null 
cultured palates were decreased relative to the wild-type fusion rates (44.4% vs 
90.0% respectively), they were not as low as the reported 17-19% seen in vivo 
(Barrow and Capecchi, 1999; Rijli et al., 1993; Wang, 2006; Zhang, 2003).  The 
finding that the palate shelves do not appear to be capable of re-orientation 
above the tongue in most cases could help to explain these differences.  
 The interaction between the tongue and palate shelves clearly only 
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explains a portion of the reported cleft palates in Hoxa2 null mice due to the 
high incidence of cleft even in the absence of the tongue.  An increase in cleft 
palate due to altered proliferation has previously been reported for Spry2 null 
animals (Welsh et al., 2007).  These mutant embryos did not have defects in 
their ability to elevate above the tongue, but still displayed a cleft palate that 
was suggested to be the direct result of increased cell proliferation.  Therefore, 
it is likely that the alteration in proliferation in Spry2 null mice leads to changes 
in the normal development of the palate that prevents palatal fusion even if they 
are capable of elevation.  
6.5 Hoxa2 Null Palates are Capable of Fusion 
 The ability of the palate shelves to fuse with one another was also 
investigated.  Palate shelves were placed in direct contact with one another and 
allowed to fuse for 72 h.  This technique investigated whether the palate 
shelves had the intrinsic ability to fuse together, without the necessity of having 
to grow together and contact one another.  The Hoxa2 null, heterozygous and 
wild-type palate shelves were all equally capable of fusion (Fig. 17).  Previous 
culture experiments removed any interference that the tongue may have 
caused, but did not eliminate any problems that resulted from altered palate 
shelf growth (Wang, 2006; Zhang, 2003).  These new findings clearly 
demonstrate that there are defects with palate development in the Hoxa2 null 
palates, but that they occur prior to fusion, and that the process of fusion is not 
altered.  
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6.6 Hoxa2 acts as a Transcriptional Repressor in the Palate 
 The Hoxa2 protein acts as a transcription factor, and therefore any 
effects that the protein has on the development of the palate is through 
regulating the expression of other genes.  In order to confirm that there is in fact 
a role for Hoxa2 within the palate proper, it was essential to determine 
downstream targets within the developing palate and characterize any changes 
to their expression profile that occurs in the absence of the Hoxa2 protein.    
 The Hoxa2 protein has previously been reported to be able to both 
activate and repress the expression of other genes during craniofacial 
development (Bobola et al., 2003; Kutejova et al., 2005; Santagati et al., 2005).  
The only direct downstream target of Hoxa2 that has been reported is Six2 
which is repressed by Hoxa2 (Kutejova et al., 2005; Kutejova et al., 2008).   
 The expression of numerous targets was investigated within the palates 
of wild-type and Hoxa2 null palates using both quantitative real time RT-PCR 
and western blot analysis to determine if the absence of Hoxa2 resulted in 
altered expression.  A number of downstream targets of Hoxa2 in the palate 
were identified all of which appear to be repressed by Hoxa2.  Msx1, Bmp4, 
Barx1, Six2, Ptx1, Lef1 and Tbx1 all display increased expression levels in 
Hoxa2 null palate shelves.  It appears that Hoxa2 is most active as a repressor 
at the early stages of palate development (E12.5 and E13.5), as for the majority 
of genes the only alterations in expression were seen at this stage.  Six2 
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expression was an exception to this phenomenon and continued to be elevated 
throughout palatogenesis in the Hoxa2 null palates (Fig. 25).  The expression of 
Tbx1 was also an exception with an increase in expression in the null palates 
only observed at E15.5 (Fig. 27).  These findings suggest that although the 
primary role of Hoxa2 may be in regulating the expression of genes early in 
palate development, there may also be a role for Hoxa2 at the later stages of 
development.     
6.7 Altered Expression of Downstream Targets Agrees with Increased 
Proliferation in Hoxa2 null Palates 
 Regulation of proliferation rates within the palate have been attributed to 
a variety of genes in the past.  As discussed in section 3.4.1 (pg 22) distinct 
pathways have been shown to regulate growth of the palate in the anterior and 
posterior regions of the palate.  The Hoxa2 protein is expressed throughout the 
entire palate shelf including the epithelium and the mesenchyme (Fig. 11).  
These data, combined with the observed increase in proliferation throughout the 
palate of Hoxa2 null embryos (Fig. 14), led me to investigate what role Hoxa2 
may play in regulating the expression of both anterior and posterior specific 
genes.  
 Cell proliferation (Santagati et al., 2005) in the anterior mesenchyme is 
regulated by Msx1 and its downstream targets (Zhang, et al., 2002).  In 
addition, within the branchial arches Hoxa2 is involved in regulating the 
expression of Msx1 (Santagati et al., 2005).  Msx1 levels at both the mRNA 
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(p<0.01) and protein levels (p<0.05) are increased at the early stages of 
palatogenesis (E12.5) in Hoxa2 null embryos (Fig. 18).  Bmp4 is a known 
downstream target of Msx1 and an essential component in the Msx1 signalling 
pathway that regulates proliferation in the anterior palate (Zhang et al., 2002).  
The expression of Bmp4 was also increased in the Hoxa2 null palate shelves 
(Fig. 19).  At E12.5, a significant increase was shown at the mRNA level 
(p<0.05) while protein levels did not increase until E13.5 (p<0.05) indicating a 
delay in translation of the mRNA message into protein (Fig. 19).  Msx1 and 
Bmp4 have been described to work within a feedback loop (Zhang et al., 2002), 
which may explain why the levels of both mRNA and protein return to wild-type 
levels relatively quickly.  Together, the increase in Msx1 and Bmp4 provide a 
mechanism by which Hoxa2 may be regulating the level of proliferation in the 
anterior region of the palate.  Increased and ectopic expression of Msx1 has 
previously been described to lead to increased proliferation throughout the 
palate (Welsh et al., 2007).  Therefore, the increase in Msx1 and Bmp4 
expression could in fact also account for the altered proliferation levels seen in 
the medial and posterior palate, either directly, or by altering the expression of 
other genes which leads to increased proliferation. 
 Alterations in the expression of the predominantly posteriorly expressed 
Barx1 gene have also been suggested to be responsible for changes in 
proliferation rates within the posterior palate (Welsh et al., 2007).  Significantly 
increased levels of Barx1 mRNA (p<0.05) and protein (p<0.05) were observed 
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in the palate shelves of Hoxa2 null embryos at E13.5 (Fig. 20).  It is unclear 
which pathway links Barx1 to proliferation, but an increase in Barx1 protein is 
predicted to lead to increases in posterior cell proliferation (Welsh et al, 2007).  
However, why expression levels return to normal is unclear but could be the 
results of a feedback loop as is the case for Msx1.   
6.8 Novel Pathway in the Developing Palate involving New Downstream 
Targets of Hoxa2 
 Hoxa2 has been demonstrated to repress Ptx1 expression in the second 
branchial arch, likely through an indirect mechanism (Bobola et al., 2003).  Ptx1 
is expressed within the palate at E15 (Lanctot et al., 1997).  Our findings show 
that Ptx1 is expressed throughout palate development (E12.5-E15.5) and as in 
the branchial arches, it is repressed by Hoxa2, with a significant increase 
(p<0.05) in both mRNA and protein expression evident at E13.5 in the Hoxa2 
null embryos (Fig. 21).  Interestingly, in the branchial arches Ptx1 is completely 
absent from the second branchial arch in the wild-type, but is ectopically 
expressed in the absence of Hoxa2 (Bobola et al., 2003).  This finding would 
suggest a much stronger repression of Ptx1 in the branchial arches than is 
observed in the developing palate.  
 The mechanism by which Hoxa2 represses Ptx1 expression in the 
branchial arches remains largely unclear.  It has been suggested that epithelial 
Fgf8 expression is an absolute requirement (Bobola, et al., 2003).  Fgf8 
expression has not been described in the murine palate.  However, a recent 
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genetic linkage study in humans did show Fgf8 mutations lead to cleft palate 
(Riley et al., 2007).  Fgf8 protein expression was observed in the developing 
palate between E12.5 and E15.5 at the mRNA and protein levels.  No 
differences in the expression levels of either the mRNA or protein were 
observed in the Hoxa2 null palate shelves (Fig. 22). Immunohistochemical 
analysis revealed that contrary to its epithelial specific expression in the first 
branchial arch, Fgf8 protein is present in both the epithelium and the 
mesenchyme of the developing palate (Fig. 23).  In the hindlimb, it has been 
suggested that while Ptx1 is not likely linked to the expression of growth factors 
such as Fgfs it may provide the cell with the ability to respond to these signals 
and therefore be involved in the regulation of growth and patterning of 
embryonic structures (Marcil et al., 2003). 
A role may exist for Hoxa2 downstream of Fgf8, which allows for its 
repression of Ptx1.  This could be through either the regulation of transducers or 
repressors of the Fgf8 signal.  Lhx8 is another known downstream target of 
Fgf8 which has previously been linked to cleft secondary palate (Inoue et al., 
2006; Zhao et al., 1999).  The expression of Lhx8 mRNA remains unaltered in 
the absence of Hoxa2 in the palate (Fig. 24).  These data would suggest that, 
although a role may exist for Hoxa2 downstream of Fgf8, not all of the Fgf8 
downstream targets are affected.  It has been well documented that numerous 
members of the Fgf signalling family are present and important in the 
development of the secondary palate (Alappat et al., 2005; Eblaghie et al., 
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2004; Goodnough et al., 2007; Lee et al., 2008; Rice et al., 2004; Riley et al., 
2007; Thomason et al., 2008) and therefore these contrary results may be due 
to redundancy between Fgf signals in regulating certain downstream targets. 
Ptx1 expression has been studied within the developing mandible and 
teeth.  Its expression has been shown to be tightly regulated by both activating 
and repressing mechanisms.  Ectopic Fgf8 signals in the mandible have been 
shown to induce and maintain the expression of Ptx1 (St. Amand et al., 2000).  
This mechanism appears to be similar to that in the branchial arches and may 
be conserved in the palate as discussed above.  In contrast, ectopic expression 
of Bmp4 represses Ptx1 in the mandible (St. Amand et al., 2000).  In the palate, 
loss of Hoxa2 expression leads to an increase in Bmp4 at E12.5 (Fig. 19) and 
Ptx1 (Fig. 21) at E13.5.  It would appear that this would be opposite to the 
observed repression in the mandible.  Multiple mechanisms could result in 
these contrary results including, alterations in the expressions in the anterior 
and posterior regions of the palate.  Bmp4 has been reported to have an 
anterior specific expression profile and therefore, it is possible that as only total 
expression was investigated Ptx1 may be repressed in the anterior region but 
increased in the posterior.  Alternatively, different factors may be involved in the 
pathway that transduces the Bmp4 signal within the palate than in the mandible.  
To determine if there is a relation between Ptx1 and Bmp4 will require further 
investigation.  
Hoxa2 has been shown to be downregulated in the branchial arches in 
 155 
the presence of exogenous Fgf (Trainor et al., 2002).  The possibility therefore 
exists, that a feedback loop occurs between Hoxa2 and members of the Fgf 
family in order to regulate the proper growth and development of craniofacial 
structures including the secondary palate.   
Hoxa2 null palate shelves show a significant increase (p<0.05) in Lef1 
mRNA expression at E12.5 (Fig. 28). To date the only role that has been 
described for Lef1 in the developing palate is at the stage of fusion.  The role of 
Lef1 in palate shelf fusion has been extensively researched (Nawshad et al, 
2007; Nawshad and Hay, 2003).  A recent study showed that Lef1 directly 
represses the expression of epithelial specific E-Cadherin while promoting the 
expression of mesenchymal markers vimentin and fibronectin (Nawshad et al., 
2007).  This mechanism clearly helps explain the role Lef1 plays in eliciting the 
Tgf-β3 dependent degradation of the midline epithelial seam.  Although the only 
previously described role for Lef1 in the palate has been at the fusion stage 
(Nawshad and Hay, 2003; Nawshad et al., 2007), its expression throughout 
development as well as the significant increase early in development in the 
Hoxa2 null mutants suggests a role earlier in palate development.  In tooth 
development, Lef1 has been shown to be critical for proper development by 
acting as a survival factor (Sasaki et al., 2005).  Additionally, Lef1 expression 
has been linked to the expression of Fgf (Eblaghie et al., 2004; Kratochwil et al., 
2002; Sasaki et al., 2005) and of Bmp4 (Kratochwil et al., 1996), both of which 
are known to be important for proper palate development.  Taken together, this 
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suggests that there may be a role for Lef1 in early palatogenesis although its 
exact function remains unclear.  
Lef1 has been shown to be involved in regulating the cell cycle 
throughout development through the regulation of genes such as cyclin D1 and 
c-myc (Reya and Clevers, 2005; Shtutman et al., 1999).  The binding of Lef1 to 
the cyclin D1 promoter has been shown to induce its expression and ultimately 
to the progression of the cell through the cell cycle (Shtutman et al., 1999; St 
Amand et al., 2000).  The increase in Lef1 expression could therefore also help 
to explain the increase in proliferation observed in Hoxa2 null palate shelves. 
 Although Lef1 has not previously been shown to be a downstream target 
of Hoxa2, it has been recently reported that there is a direct link between Ptx2 
and Lef1 in the developing embryo (Amen et al., 2007; Vadlamudi et al., 2005).  
Ptx2 and Ptx1 are members of the Ptx subfamily of paired-like homeodomain 
genes and share a high level of sequence homology and have been shown to 
demonstrate similar DNA-binding specificities in vitro (Tremblay et al., 2000).  
This suggests that the increase in Lef1 and Ptx1 expression in Hoxa2 null 
embryos may be linked.  Both Lef1 and members of the Ptx family are known to 
act downstream of the Wnt canonical pathway, which has been shown to be 
important in cell survival and proliferation (Amen et al., 2007).  Lef1 has two 
known isoforms, the full length isoform is dependent on β-catenin while the N-
terminally truncated form is not.  Ptx2 appears to differentially regulate the 
expression of each Lef1 isoform, and it may through this mechanism be capable 
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of regulating growth and migration (Amen et al., 2007).  
Ptx1 has also been linked to a number of other genes expressed within 
the developing palate.  Ptx1 null embryos show a significant decrease in the 
expression of Barx1 in the mandible (Mitsiadis and Drouin, 2008).  In Hoxa2 null 
palates, there is a significant increase in the expression of both Ptx1 (Fig. 21) 
and Barx1 (Fig. 20) at E13.5.  These data suggest that there may also be a link 
between Ptx1 and Barx1 expression in the palate.  This would once again link 
Ptx1 to a known proliferative pathway in the palate.   
Tbx1 expression was shown to be significantly increased at E15.5 in the 
palates of Hoxa2 null embryos (Fig. 27).  This increase in expression may also 
be linked to the observed increase in Ptx1 expression earlier in palatogenesis.  
In the dental epithelium, loss of the Ptx1 gene resulted in a subsequent 
decrease in the levels of Tbx1 (Mitsiadis and Drouin, 2008). 
The isolation and characterization of Ptx1, Barx1, Lef1 and Tbx1 as 
downstream targets of Hoxa2 in the palate represents a new and interesting 
pathway within the developing palate, which may be important in regulating the 
normal growth of the palate.  Hoxa2 appears to repress all 4 of these gene 
targets.  Its repression of Ptx1 is unlikely to be direct based on the regulation in 
the branchial arches (Bobola et al., 2003)/  It is more likely to occur through, or 
involve, the expression of Fgf8.  Barx1, Lef1 and Tbx1 could all be downstream 
of Ptx1, and provide a second pathway through which Hoxa2 maintains normal 
proliferation in the palate.    
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6.9 Novel Six2 Expression 
Six2 is expressed in the mesenchyme of the nasal prominences of E11.5 
mice (Brodbeck et al., 2004; Fogelgren et al., 2008; Ohto et al., 1998; Oliver et 
al., 1995).  Brachyrrhine mice, which have been linked to decreased Six2 
expression throughout the developing embryo, were described to have an 
absence of the primary and secondary palates (McBratney et al., 2003; Singh et 
al., 1998).  Contrary to this finding, Six2 knockout mice did not display any 
craniofacial defects (Self et al., 2006).   These contrary results make it difficult 
to determine the exact role of Six2 in regulating the development of the murine 
face.    
 Hoxa2 has previously been shown to act directly on the Six2 promoter to 
totally repress its expression in the second branchial arch (Kutejova et al., 2005; 
Kutejova et al., 2008; Santagati et al., 2005).  Overexpression of Six2 in the 
second branchial arch of wild-type mice results in a phenotype similar to Hoxa2 
null mutants (Kutejova et al., 2005).  Six2 expression was detected for the first 
time within the developing palate.  mRNA expression was detected using real 
time RT-PCR (Fig. 25 A).  In the wild-type mouse palate, Six2 mRNA 
expression is relatively constant throughout palatogenesis, although appearing 
to peak at E12.5 and decrease slightly at E15.5.  As observed in the branchial 
arches, Hoxa2 appears to act as a repressor of Six2 expression at early stages 
of palatogenesis, with a significant increase (p<0.05) observed at both E12.5 
and E13.5 in null mutants. The presence of Six2 protein was also confirmed 
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within the developing palate.  The upregulation in Six2 expression in Hoxa2 null 
mice was also observed at the protein level in immunohistochemical analysis of 
the palate (Fig. 26) and western blot (Fig. 25 B and C).  
 Detection of Six2 expression within the developing palate provides an 
interesting new target that requires further investigation.  A link between Six2 
and cell proliferation within a subset of CNCC has been reported (Ma and 
Lozanoff, 1999).  It is therefore possible that the observed increase in Six2 
expression is directly related to the increase in the level of proliferation within 
the palate.  Little data has been reported on possible downstream targets of 
Six2, especially in craniofacial development.  In the kidney, it was shown that 
Six2 was capable of activating the expression of both glial-cell-line-derived 
neurotropic factor (Gdnf) and its own expression (Brodbeck et al., 2004).    
The Six family of transcription factors have been shown to work in 
conjunction with the Eya family of proteins, to regulate the expression of genes 
(Purcell et al., 2005; Zou et al., 2004).  Eya1 null embryos have been reported 
to display a cleft secondary palate (Alkuraya et al., 2006; Xu et al., 1999).  Also 
of interest, is the finding that Eya1 is upstream of the Tbx1 gene in the 
developing mouse ear (Friedman et al., 2005).  The potential interactions 
between Six2, Eya1 and Tbx1 provide another downstream pathway of Hoxa2 
that is important in the developing palate.  Further analysis of these targets, as 
well as identification of other potential components of this pathway, could 
provide new insights into the players involved in the regulation of palatogenesis.    
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6.10 Novel Htra3 Expression 
 Htra3 expression, which has not previously been described in the 
developing palate, was detected at the mRNA and protein levels for the first 
time by means of real time RT-PCR, western blot and immunohistochemical 
analysis.  In the wild-type mouse palate, Htra3 mRNA is expressed between 
E12.5 and E15.5 with levels steadily increasing throughout palatogenesis (Fig. 
29). Western blot analysis showed that Htra3 protein is expressed throughout 
palate development, although levels appear to remain constant between E12.5 
and E14.5.  This constant level of protein expression suggests that although the 
level of mRNA is increasing within the palate, there does not appear to be an 
overall increase in amount of protein within the palate. 
 Immunohistochemical analysis revealed that Htra3 is expressed 
throughout the palate (Fig. 30).  Expression of Htra3 protein is the highest in the 
medial regions in the palate at E13.5, E14.5 and E15.5.  At E13.5 and E14.5 the 
majority of Htra3 expression appears to be located in the proximal areas of the 
palate with little to no expression in the mesenchyme of the shelves, although 
expression is visible in the epithelium.  At E15.5, expression increases to 
include the mesenchyme as well as the epithelim.  This increase in the area of 
expression occurs at the same point in which the palate shelves are fusing 
together.     
 Htra3 is known to bind to and inactivate numerous members of the Tgf-β 
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family including: Tgf-β1, Tgf-β2, Bmp4 and Bmp2 (Tocharus, et al., 2004).  Both 
Bmp4 and Bmp2 have been shown to be crucial in the regulation of cell 
proliferation within the palate (Zhang, et al., 2002).  Limiting the expression of 
Htra3 to the proximal regions of the palate at E12.5 and E13.5 may ensure that 
Bmp2 and Bmp4 are not degraded, allowing them to function in promoting cell 
proliferation. The increase in the domain of Htra3 at E14.5 may play a role in 
the degradation of these proteins at later stages of palatogenesis when 
proliferation levels decline and palate shelves fuse.  In addition, Tgf-β1 has 
been shown to act to promote cell survival in the palate epithelium, inhibiting the 
ability of Tgf-β3 to degrade the midline epithelial seam (Martinez-Alvarez, et al., 
2004).  Htra3 may act to degrade Tgf-β1 in the epithelium late in palatogenesis 
allowing for Tgf-β3 to induce fusion.  Due to the large number of potential Htra3 
targets known to be expressed in the developing palate, and its increased 
expression throughout palatogenesis, the role of Htra3 in the palate is an 
interesting area of study and may provide further insight into the regulation of 
palate development. 
Hoxa2 has been shown to bind to the genomic sequence of Htra3 in vivo; 
in Hoxa2 null embryos Htra3 shows an increase in expression throughout the 
spinal cord and hindbrain (Akin, 2004).  In contrast, within the palate shelves 
Htra3 expression does not seem to change in the absence of Hoxa2 (Fig 29).  
The difference in the ability of Hoxa2 to regulate the expression of Htra3 is likely 
to be due to the different subset of co-factors that are expressed in the spinal 
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cord and palate.   
6.11 Conclusion 
 Hoxa2 mRNA and protein is present in the palate between E12.5 and 
E15.5 (Fig. 9, 10 and 11).  The confirmation of Hoxa2 within the developing 
palate shows that although Hoxa2 is not expressed in the migrating CNCC of 
the first branchial arch, it is activated in the cells arising from this arch at later 
stages of development.  This is contradictory to the current theory that all of the 
derivatives of the first branchial arch are devoid of Hox expression.  The Hoxa2 
protein is most highly expressed in the palate at E13.5, an age when there is 
significant growth in the palate shelves. High levels of expression are also seen 
in the midline epithelial seam as the palates fuse with one another (Fig. 11). 
 The growth of palate shelves is altered in Hoxa2 null embryos.  An 
increase in the rate of proliferation is observed in the palates of null embryos, 
without an apparent increase in the level of apoptosis (Fig. 14, 15 and 16).  
Problems also exist in the ability of the palate shelves to reorient from their 
initial vertical position, to the horizontal position above the tongue (Fig. 12).  
This was previously hypothesized to be the direct result of altered tongue 
musculature.  Increased cell proliferation provides an alternate mechanism for 
the inability of the palate shelves to reorient.  Organ culture experiments clearly 
demonstrated that the palate shelves of wild-type and Hoxa2 null embryos are 
equally capable of undergoing fusion when placed in contact (Fig. 17).  
Together, these data suggest that defects in the development of Hoxa2 null 
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palates are primarily the result of altered growth of the palate shelves.     
 The direct role of Hoxa2 appears to be as a transcriptional repressor 
within the developing palate.  Msx1, Bmp4, Barx1, Ptx1, Six2, Lef1 and Tbx1 all 
have increased expression in the Hoxa2 null palate shelves compared to wild-
type controls.  Msx1, Bmp4 and Barx1 expression have previously been shown 
to be part of a common pathway that regulates cell proliferation within the 
development.  Increase in the expression of these genes is in agreement with 
the increase in proliferation.  Additionally, Ptx1, Lef1, Tbx1 and Barx1 may be 
linked together in a common pathway involving Hoxa2, which could also lead to 
the observed increase in proliferation.   
 Three novel targets were also identified within the developing palate 
(Six2, Fgf8 and Htra3).  Six2 was shown to be downstream of Hoxa2 within the 
palate, while Fgf8 and Htra3 expression was not altered by the loss of Hoxa2. 
 A schematic representation of the signalling pathways known to function 
within the palate along with the predicted role of Hoxa2 and its newly identified 
targets can be seen in Figure 32.  
 Together these data all point towards a direct role for Hoxa2 in regulating 
the development of the secondary palate, particularly in maintaining normal cell 
proliferation rates.   
6.12 Future Directions 
 A complete understanding of the role of Hoxa2 and its downstream 
targets within the developing palate will require additional experiments.   How 
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Figure 32. Overview of the signalling pathways involved in regulating  
palatogenesis, highlighting the role of Hoxa2  
Schematic representation of the major signalling pathways known to be 
involved in regulating murine palatogenesis.  Hoxa2 downstream targets are 
highlighted in orange, two novel targets unrelated to Hoxa2 are denoted in 
brown. Green arrows denote activation of one factor on the other.  Red lines 
denote repression of one factor on another.  Black lines represent the effects of 
that factor on the denoted process (proliferation or fusion), if crossed by red 
lines the process is inhibited by the factor.   Dotted lines represent predicted 
interactions. The pink area representing the epithelium, grey represents the 
mesenchyme. Factors are shown in their relative anteroposterior region of 
expression with factors with an exclusively anterior expression pattern in purple, 
posterior expression indicated in yellow.  Expression patterns that are not 
region specific or are confirmed are shown in blue.   
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the loss of Hoxa2 affects the spatial expression of its downstream targets 
remains to be investigated.  Due to the importance of proper anteroposterior 
expression of genes within the palate, it is possible that the effect of Hoxa2 on 
gene expression resides in regulating their expression domains in addition to 
their total expression level.   To gain a complete overview of the area of the 
palate that genes are expressed within, a whole mount system would need to 
be developed.  Whole palate in situ analysis has previously been reported by 
other groups (Li and Ding, 2007; Liu et al., 2005; Welsh et al., 2007).  This 
technique is limited by the fact that it only evaluates the expression of mRNA, 
and therefore it may be desirable to attempt to optimize a whole mount 
immunohistochemical analysis system to visualize the areas of protein 
expression, although this technique has not been reported in the palate to date.   
Determination of whether any of the newly identified targets are directly 
repressed by Hoxa2 is required for a better understanding of its role in 
regulating palate development.  The most likely candidates for direct regulation 
are Msx1 and Six2.   It is possible that Barx1, Bmp4, Lef1 and Tbx1 are also 
directly repressed by Hoxa2.  To determine if these targets are directly 
downstream of Hoxa2 it is necessary to show whether Hoxa2 is capable of 
recognizing and binding to the promoter or coding region of the DNA encoding 
for each target.  Chromatin Immunoprecipitation (ChIP) could be used to 
determine the ability of Hoxa2 to bind to the genomic sequences of these 
genes.  This could be performed in vivo, nuclei samples would be isolated from 
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the palate and the DNA and protein cross-linked. A Hoxa2 specific antibody 
would then be used to isolate the Hoxa2 protein and any bound DNA.  
Following a reversal of the crosslinking, PCR analysis can be performed to 
determine if the DNA that was bound by Hoxa2 falls in the promoter or coding 
regions of the gene targets being examined.   
ChIP analysis will provide valuable insight into what targets are 
potentially directly downstream of Hoxa2.  Further examination would be 
required to confirm that a direct regulation is occurring.  Electrophoretic mobility 
shit assays (EMSA) would allow the direct examination of Hoxa2 protein binding 
to target sites.  In addition, it would be desirable to confirm that Hoxa2 is 
capable of repressing downstream genes by binding to any isolated target 
sequences in vivo.  This can be achieved by cloning the isolated binding 
sequences into a vector upstream of a reporter gene such as luciferase.  This 
vector can be cloned into a cell line along with a Hoxa2 expression vector.  If 
the effect of Hoxa2 is direct, the level of activity of the reporter gene should be 
altered in the presence of Hoxa2 expression.  Taken together, these data would 
allow for the identification of targets that are directly downstream of Hoxa2 
within the developing palate.        
 Further investigation into the potential of a Hoxa2-Ptx1 pathway in the 
palate which involves Barx1, Lef1 and Tbx1 is also required. It has been 
suggested that in the branchial arches Fgf8 is responsible for mediating the 
signal between Hoxa2 and Ptx1 (Bobola et al., 2003).  In order to investigate if 
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this link is occurring within the palate, an Fgf8 antagonist could be incorporated 
into organ cultures.  If the increase in Ptx1 expression in the Hoxa2 null palate 
shelves requires Fgf8, then blocking its activity should prevent the increased 
Ptx1 expression seen in these null embryos.  If this is the case, then 
examination of how growth and fusion are altered by preventing this increase in 
Ptx1 could also provide insight into its role in regulating palate development.  
Barx1, Lef1 and Tbx1 are all potentially involved in the pathway with Ptx1 and 
therefore examining their expression patterns would also provide a more 
complete picture of how these genes interact. 
  To confirm the two novel pathways that have been suggested here will 
require further analysis.  Addition of siRNA specific for any of the genes shown 
to be upregulated by Hoxa2 would provide valuable information.  Knocking 
down the increased expression of these genes individually followed by 
characterization of growth and fusion of the palates as well as expression of the 
other targets identified would provide a more complete picture of the role of 
these downstream targets and how they are interconnected.  It is possible that 
knocking down increased expression of one or more of the downstream targets 
will be capable of rescuing the observed cleft palate in Hoxa2 null embryos. 
Eya1 expression would also be an interesting target to investigate within 
the palate.  Determination of whether Eya1 expression is altered in Hoxa2 null 
palates could also provide an interesting link between Hoxa2 and 
palatogenesis.  
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The novel expression of Htra3 within the palate provides an exciting new 
target that could potentially play an important role in regulating palatogenesis.  
Htra3 is capable of binding to and inactivating members of the TGF-β family 
(Tocharus et al., 2004).  Due to important roles that members of the TGF-β 
family play in palate development, it would be interesting to determine how their 
expression and activity is altered by Htra3.  Ideally, an Htra3 knockout mouse 
line would be developed, but this would be costly and time-consuming.  
Knocking down Htra3 expression in culture, using a siRNA construct, would be 
an easier starting point.  Additionally, increasing Htra3 expression in culture, 
potentially by retroviral infection, could aid in elucidating any potential role it 
may play in the developing palate.  Following the up or downregulation of Htra3 
palate cultures could be examined for growth, fusion and expression levels of 
TGF-β family members.  Htra3 is an extracellular protein, capable of degrading 
extracellular matrix proteoglycans, including decorin and biglycan (Tocharus et 
al., 2004).  Examination of the composition of the extracellular matrix when the 
levels of Htra3 are altered would also be required.   
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